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ABSTRACT 
 
N-TERMINAL IMINE DERIVATIZATION FOR ENHANCED DE NOVO 
PEPTIDE SEQUENCING: A STUDY OF THE FRAGMENTATION PATTERN 
GENERATED FROM CID OF PEPTIDE-IMINES 
 
 
By 
Khiry L. Patterson 
April 2020 
  
Dissertation supervised by Dr. Michael Van Stipdonk  
Tandem mass spectrometry (MS/MS) and collision-induced dissociation (CID) remain 
two of the most essential tools used for peptide and protein identification in proteomics. Notably, 
the unique product ion distributions generated from CID are used, in part, to determine 
peptide/protein sequence, whether by comparison to known peptide fragmentation patterns, or 
searching sequence databases that attempt to predict fragmentation. However, an impediment to 
reliable identification by interpretation of CID mass spectra may be caused by an incomplete 
understanding of peptide fragmentation mechanisms, including sequence rearrangement 
pathways (sequence scrambling) at increasingly higher stages of MS/MS. This work reports the 
product ion distributions and fragmentation mechanisms derived from CID of model imine-
modified peptide ions that can inform and enhance MS/MS de novo sequencing efforts via N-
terminal derivatization.  
 v  
  
In this work, model peptides were derivatized by reaction with salicylaldehyde to create 
N-terminal imines (Schiff bases). Collision-induced dissociation of the protonated peptide-
imines generally produced complete series of the sequence informative a and b-ions, now 
undoubtedly characteristic of the peptide ion species. However, a novel product ion was also 
observed, denoted the yǂ ion, determined by IRMPD spectroscopy and density functional theory 
to be generated from the elimination of the N-terminal amino acid residue despite the N-terminal 
modification. It was concluded that the pathway involved a nucleophilic attack by an amide N 
atom and the possible formation of an imidazole-4-one intermediate, which collapses to generate 
a truncated, protonated peptide-imine with a conserved sequence structure.   
N-terminal imine-modification was postulated to eliminate sequence scrambling events, 
presumably by eliminating the macrocyclic b-ion mechanism implicated in the sequence 
rearrangements. The fragmentation pattern of imine-modified leu-enkephalin unambiguously 
revealed that CID of the peptide-imine species does not generate previously determined 
scrambled ions observed for unmodified YGGFL.   
CID mass spectra of Ag-cationized imine-modified peptides were also obtained.  
Interestingly, an apparent even-electron, [M-H]+ peptide ion was generated by the loss of AgH. 
Isotope labeling explicitly identified the imine C-H group as the hydrogen source, implicating 
an imine → nitrile transformation. CID of the [M–H]+ ions generated sequence ions analogous 
to those produced from the [M+H]+ species of imine-modified peptides, however less 
extensively.  
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CHAPTER 1  
MASS  SPECTROMETRIC  CHARACTERIZATION  OF 
PEPTIDES AND PROTEINS  
 
 
 
1.1 An introduction to Proteomics  
As so many of the cellular processes in biological systems are governed and dependent 
upon interactions at the molecular level, it is crucial to characterize the structure, behavior, and 
function of biomolecules to address the complexities of health, disease, and disease 
prevention/intervention. Many fields of study are dedicated to understanding biological systems, 
each with a particular focus on a critical biomolecule. These include the complete set of an 
organisms’ DNA (genomics),1-3 a cell or cell populations set of RNA (transcriptomics),4, 5 and – 
germane to this dissertation – the proteins produced and modified by an organism/system 
(proteomics).6, 7  
Specifically, proteomics is the large-scale study of protein interaction, expression, 
function, and structure.8 Discovery in proteomics arguably yields some of the most significant 
information for understanding the mechanisms of life, as proteins are a diverse and complex set 
of biomolecules directly involved in virtually every chemical process present in the cells of 
living organisms. Proteins work as antibodies binding to specific foreign molecules (i.e., viruses 
and bacteria), enzymes executing chemical reactions, as transport carrying small molecules in 
and out of cells, and as messengers transmitting signals to coordinate biological processes.9, 10 
Inescapably, investigating biological mechanisms require in-depth proteomic  
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studies to illuminate protein function – a feat that must include accurately identifying protein 
structure.  
  
1.2 The significance of protein structure to protein function  
Proteins are made up of a series of amino acids covalently bonded together. Each amino 
acid residue (a term used to indicate the loss of water during amide bond formation) has an 
identifiable molecular mass (except isobaric residues leucine and isoleucine) arising from its 
alpha carbon side chain that varies in size, structure, and electric charge (Figure 1.1a and Figure 
1.1b. The sequence of amino acids is known as a proteins primary structure (Figure 1.1c), where 
intermolecular interactions (i.e., hydrogen bonds, ionic bonds, van der Waals attractions) 
between residues and hydrophobicity, direct how polypeptides fold into unique higher-level 
protein structures.9-11 The arrangement of the 20 common amino acids into different 
combinations/sequences gives rise to considerably different three-dimensional structures, thus 
properties and functions.  
Changes in sequence can alter hydrophobicity and solubility, give rise to disease (i.e., 
sickle-cell anemia and Duchenne muscular dystrophy), and destroy the ligand binding site on a 
protein surface.9, 10, 12 Even folding and unfolding rates of two- and three-stage proteins can be 
predicted directly from sequence.12, 14 Evolutionary relatedness/families can be established from 
sequence or conserved residues between sequences and used to predict protein function by 
comparing the discovered sequence to that of previously studied proteins.10, 15 Undoubtedly, 
accurate sequencing of peptides and proteins is invaluable to efforts for uncovering protein 
bioinformation.   
  
Peptide/protein structure  
 
Figure 1.1 Peptide/protein structure. a) 20 common amino acids b) amino acid residue masses c) stages of protein structure; 
primary (sequence), secondary (regions stabilized by hydrogen bonding between atoms), tertiary (3D polypeptide shape determined 
by regions stabilized by side-chain interactions), quaternary (two or more associated polypeptide regions).9-11  
  
a)  b )  
c )  
3 
 4  
  
Many bioanalytical techniques have been used to progress proteomic studies such as but not 
limited to gel electrophoresis,16 liquid chromatography,17 nuclear magnetic resonance (NMR) 
spectroscopy,18 X-ray crystallography,18 and arguably one of the most essential and adaptive 
techniques for elucidating protein/peptide structure and sequence – mass spectrometry.19-25  
  
1.3 Mass spectrometric approaches to proteomics  
Mass spectrometry (MS) (discussed in more detail in section 2.1) is an essential analytical 
method that has been used extensively to determine peptide/protein sequence and structure.26-35 
Biological MS utilizes soft ionization techniques such as electrospray ionization (ESI) and 
matrix-assisted laser desorption/ionization (MALDI) to produce intact protonated peptide and 
protein ions (referred to as precursor ions or parent ions) in the gas phase. The formed [M+zH]z+ 
ions (where z is the number of protons added to give charge to the molecule) are then separated 
according to their mass-to-charge ratios (m/z) by a mass analyzer.26-29 Additionally, tandem mass 
spectrometry (MS/MS or MSn) (described in more detail in section 2.4) is a technique that uses 
energetic collisions with a non-reactive gas to fragment a precursor ion into smaller product 
ions.36, 37 The result of both mass spectrometry and tandem mass spectrometry is a mass spectrum 
constructed by plotting ion intensity as a function of m/z, from which the m/z values of either 
precursor or products ions are used to determine or confirm peptide/protein identity.36, 37  
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Proteomic Approaches  
 
  
  
 
Figure 1.2 Proteomic approaches. Top-down and Bottom-up proteomics are the two 
generalized overarching approaches to proteomic studies. Shotgun bottom-up proteomics 
indicates the specific identification of proteins in complex mixtures using high-performance 
liquid chromatography (HPLC) MS.38-41  
  
Mass spectrometric studies are typically approached either through “top-down” also 
known as “protein-centric” and “bottom-up” also known as “peptide-centric” strategies (Figure 
1.2).38-41 In top-down proteomics, the m/z values of intact ionized proteins (precursor ions) and 
the m/z values of the resulting fragment ions (product ions) are used to determine the proteins 
amino acid sequence.38-40 Bottom-up proteomics classically utilizes the peptide mass-
fingerprinting method (PMF) where proteins in complex mixtures are first separated then 
cleaved into smaller peptide components by site-specific enzymatic digestion (e.g., trypsin, Lys-
C, pepsin) before mass analysis.42-44 The smaller peptide fragments are ionized and separated 
using a mass analyzer (MS), followed by the isolation of a fragment ion and subsequent 
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fragmentation event in the gas phase (i.e. CID (section 2.4.1)) and mass analysis of the resulting 
product ions (MSn).42-44 The identification of peptides and proteins is completed by matching the 
unique mass spectra to the mass spectra of known peptides using database search algorithms.26  
  
1.4 Protein database searching  
One of the essential aspects of bottom-up proteomics is the protein database software and 
algorithms (such as SEQUEST and MASCOT) used to identify peptides from mass spectrometry 
data.45-49 As mentioned above, database search algorithms in general attempt to match a 
combination of precursor ion m/z values and product ion m/z values to those predicted from in 
silico digestion or theoretical fragmentation of the peptides derived from the in silico digestion 
of a protein with a known sequence.26 The database software then uses a scoring function to 
evaluate the “matching” quality of each experimental mass spectrum to one contained in a 
database, where the highest score is known as the peptide-spectrum match (PSM).48, 49  
The validity of a PSM is often established using the target-decoy method. This method 
accompanies a “nonsense” or “decoy” database of similar size and amino acid composition to 
the database of known, genome-derived proteins typically by reversing each protein’s amino 
acid sequence in the database.50, 51 At a given PSM score a corresponding false discovery rate 
(FDR, Equation 1.1) is calculated to quantitate the quality of the score in order to avoid a false 
positive.51, 52  
 
Equation 1.1 𝐹𝐷𝑅 @ 𝑠𝑐𝑜𝑟𝑒, 𝑠 =  
𝑡ℎ𝑒 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑖𝑛𝑐𝑜𝑟𝑟𝑒𝑐𝑡 𝑚𝑎𝑡𝑐ℎ𝑒𝑠 𝑤𝑖𝑡ℎ 𝑎 𝑠𝑐𝑜𝑟𝑒 > 𝑠
𝑇𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑚𝑎𝑡𝑐ℎ𝑒𝑠 𝑤𝑖𝑡ℎ 𝑎 𝑠𝑐𝑜𝑟𝑒 >𝑠
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The FDR corresponds to the ratio of two times the number of decoy database PSMs and the total 
number of PSMs.52 The probability that a spectrum with a given FDR score is misidentified can 
be determined by calculating the local FDR (LFDR), defined at a specific score to be the number 
of incorrect matches with the same score divided by the number of matches with that score.52  
The quality and validity of database methods can negatively be affected, resulting in a 
false positive PSM by factors including:  
1. Low-quality mass spectra.53   
2. Enzymatic digestion at abnormal sites.54  
3. Errors in charge state determination.54  
4. Misinterpretation of protein modifications.54  
5. Incomplete bioinformatics (including missing and undiscovered proteins to an  
insufficient understanding of the complex fragmentation chemistry).55  
6. Incomplete (limited) database search space.56  
  
The latter factor may arguably be particularly deleterious to peptide/protein identification, given 
database search space is often restricted by experimenters to limit the number of variable post-
translational modifications (PTMs) that can negatively affect peptide sequence matching by 
generating false-positive identifications.57 Customization of the database search space in this 
way has been shown to improve the false discovery rate.58, 59 However, if the true sequence of 
the sample includes a PTM that lay outside the limited list, then the scoring algorithm will 
misidentify the protein/peptide. Additionally, PTMs would alter the mass-to-charge ratio and 
product ion distribution. Consequently, modified peptides are thought to comprise at least one 
third of unassigned mass spectra.60 This hole in bioinformation is particularly problematic, given 
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many PTMs significantly impact the specificity and activity of proteins and have been implicated 
in disease processes.61, 62 Similar approaches to eliminate false positives caused by abnormally 
cleaved peptides can also be employed for database sequencing.58 However, disregarding PTMs, 
and abnormal or inadequately understood peptide fragmentation presents a disadvantage of 
database sequencing methods that can lead to unsuspecting misidentifications, particularly of 
artificially created, novel, mutated, modified or lesser known peptides/proteins. In these cases, 
when database searches can be significantly compromised, the next recourse is to employ 
bottom-up, de novo sequencing strategies.  
  
1.5 De novo sequencing  
De novo peptide sequencing is the process of direct interpretation of peptide product ions 
(aka. fragment ions) generated from tandem (MSn) mass spectrometry experiments.63, 64 The 
method uses the mass difference between fragment ions to calculate the unique mass of amino 
acid residues from the peptide backbone. The masses and mass differences of the product ions 
are then used to piece together the correct amino acid sequence.26 Computer software is also 
available that utilizes de novo sequencing to predict and assign peptide fragment mass values 
and mass differences.65-67 Additionally, the generated product ions can be isolated, fragmentated, 
and the resulting mass spectrum directly interpreted for sequence information – utilizing the 
power of multiple MSn stages possible with ion-trapping instruments (section 2.3.2).26 In this 
way, peptide sequencing through direct interpretation of mass spectra generated from the 
fragmentation of specifically novel and/or lesser documented peptides/proteins can be achieved 
where database methods are unsuccessful. Inevitably, de novo peptide sequencing must be 
utilized advance new discoveries in proteomics, revealing the central scientific aim of this 
 9  
  
research – to enhance de novo peptide sequencing methods. However, it is important to note 
either by software or by direct interpretation of mass spectra, the task of peptide sequencing is 
better facilitated by a sufficient understanding of peptide fragmentation and many studies have 
sought to advance this knowledge.26-35, 68-70  
  
1.6 Protonated peptide fragmentation  
The widely accepted approach to understanding the dissociation of protonated peptides is 
the pathways in competition model (PIC).26 It explains that under low-energy collision 
conditions the dissociation of protonated peptides can be described as a competition between 
charge-remote and charge-directed peptide fragmentation pathways (PFPs).26 The complicated 
fragmentation process can more easily be broken up into three stages: pre-cleavage, bond 
cleavage, and the post-cleavage (Figure 1.3).26 During the pre-cleavage phase the ionizing 
“mobile” proton may be positioned at any competing reactive site along the peptide backbone.26 
Intramolecular interactions along the peptide backbone then lead to intermediate structures that 
are activated by some mechanism (i.e., CID (section 2.4.1), IRMPD (section 2.4.2)) leading to 
bond cleavage.26 The resulting products are a protonated product ion observable by mass 
spectrometry and a neutral fragment(s) indicated by the mass difference between the product and 
precursor ion.26   
Charge-remote pathways are distinguished by intramolecular interactions that lead to 
backbone cleavages that occur physically remote from the position of the ionizing proton.26 The 
fragment ions generated from charge-remote pathways are self-descriptively termed non-
sequence ions.26 For charge-directed pathways however, the intramolecular interactions are 
facilitated by the migration and position of the ionizing proton to the various reactive sites on 
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the peptide backbone, leading to bond cleavages physically near the protonation site.26, 71-75 
Peptide dissociation as a result of charge-directed pathways primarily lead to product ions termed 
sequence ions, described by three different types of sequence identifying peptide bond cleavages 
that keep amino acid side chains intact (Figure 1.4): the “a/x” alkyl carbonyl bond (CHR-CO), 
the “b/y” peptide amide bond (CO-NH), and the “c/z” aminoalkyl bond (NHCHR).26, 29,76 The 
a/x, b/y, and c/z sequence ions take on the form Px, where P is the ion type of the corresponding 
bond cleavage and the subscript x represents u-1 where u is equal to the number of amino acid 
residues in the complete peptide sequence. Note the subscript x is interpreted from the N- to the 
C-terminus for a-, b-, and c-type ions and from the C- to the N-terminus for x-, y-, and z-type 
ions. Though each bond cleavage has the potential to generate two types of sequence ions (a|x, 
b|y, and c|z respectively), the product ion that predominates in the mass spectrum is in part 
determined by whichever species has the higher affinity for the ionizing proton, as well as the 
internal energy distribution of the ion population.26, 77, 78 As a result, the generation of a classical 
sequence ion can be described as a dissociation of an intermediate dimer ion.  
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Pathways in competition (PIC)  
  
 
Figure 1.3 Pathways in competition (PIC). Flowchart of competing dissociation pathways.26  
 
Sequence ions  
 
Figure 1.4 Sequence ions. The dotted lines indicate bond cleavage resulting from peptide ion 
energetic collisions with a nonreactive gas (i.e., helium). a, b, and c ions contain the N-terminus, 
while x, y, and z ions contain the C-terminus. Not shown is the ionizing proton (hydrogen) that 
directs peptide bond cleavage.26, 76  
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1.7 Protonated peptide fragmentation pathways  
  
Determining the dissociation pathway leading to the generation of product and sequence 
ions from protonated peptides is essential to creating an adequate understanding of the ion types 
fragmentation chemistry. Additionally, working fragmentation pathways with defined initiation 
steps and product ion structures enhances the ability to interpret the fragmentation pattern and 
behavior of both precursor and product ions. Given under low energy CID the commonly 
observed sequence ions generated from protonated peptides are the a-, b-, and y-type ions, the 
fragmentation pathways of these common ions have been investigated.26  
  
 
1.7.1   b x   –   y z   pathway   
Scheme 1. 1  b x  –  y z  pathway  
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Migration of the ionizing proton from one reactive site to the nitrogen of the amide bond 
to be cleaved initiates the bx – yz pathway (Scheme 1.1).26 Nucleophilic attack by the neighboring 
N-side oxygen on the protonated amide bond carbon center leads to the proton bound bx 
oxazolone – yz dimer under low energy collision conditions. The formation of either protonated 
monomer after CID is determined by the thermochemistry of the two possible sequence ion 
species and each monomers proton affinity.26 Contrastingly, proton migration to an amide 
oxygen has also been suggested for bx - yz formation.
26 Though amide oxygen protonation is 
energetically favored over protonation at the amide nitrogen, the dissociation channels of the 
amide oxygen pathway are not thought to be active under low energy CID.26  
  
1.7.2 Side-chain effect: non-classical b-ion  
  
 
  
 
Scheme 1.2 Non-classical b-ion  
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Nucleophilic attack by the amino acid side chain nitrogen of Arg, Lys, Asp, Glu, and His 
(or by the side chain carbonyl oxygen of Gln and Asn) on the neighboring C-side protonated 
amide bond carbon center also leads to amide bond cleavage but with “non-classical” b-ion 
formation (Scheme 1.2).26 Competition with the bx - yz pathway can lead to an isomeric mixture 
of the oxazolone and non-classical b-ion forms.  
  
 
1.7.3     a 1   –   y z   pathway   
Scheme  1.3  a 1  –  y z  pathway  
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After the migration of the ionizing proton to the second N-terminal amino acid amide 
nitrogen, a trimer of a protonated N-terminal and C-terminal monomer with a loosely bound CO 
loses the CO forming the N-side and C-side dimers (Scheme 1.3).26 Dissociation of this dimer 
leads to the formation of either the a1 or yz ion.  
  
1.7.4 Aziridinone pathway  
 
  
 
Scheme 1.4 Azirdinone pathway  
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The aziridinone pathway is a charge directed pathway that results in the formation of an 
aziridinone - yz proton-shared dimer (Scheme 1.4).
26 If dissociation of the dimer results in the 
nitrogen protonated aziridinone monomer, structural instability leads to a1 ion formation through 
the loss of CO. In comparison to the a1 – yz pathway, theoretical investigations of dipeptides 
have indicated the aziridinone pathway to be less kinetically and energetically favored.26  
  
1.7.5 Secondary fragmentation: bx – bx-1 pathway  
 
Scheme 1.5 bx – bx-1 pathway  
 17  
  
Although b-ions are typically generated through dissociation of protonated peptide 
precursor ions, b-ions can also be generated via breakdown of product ions. Investigation of the 
bx → bx-1 pathway for various Leu-enkephalin derivatives have shown approximately 50 % of 
the observed b3 ions originate directly from the breakdown of the corresponding b4 ions.
26 
However, the mechanistic details of the transformation remain unclear. Scheme 1.5 depicts a 
proposed one-step charge directed mechanism where the adjacent amide carbonyl oxygen attacks 
the oxazolone imine carbon to generate an aziridinone derivative and the protonated bx-1 ion.26  
 
 
Scheme 1.6 bx – ax – bx-1 pathway  
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In contrast Scheme 1.6 depicts an indirect charge directed mechanism that first goes 
through the bx → ax pathway transformation by the loss of CO.26 This is followed by an ax →  
bx-1 transformation via a nucleophilic attack on the C-terminal a-ion carbonyl carbon by the 
adjacent carbonyl oxygen – losing an immonium ion and forming the oxazolone bx-1 ion.  
However, investigation of these two pathways has indicated neither mechanism is likely for bx 
→ bx-1 formation under low energy collision conditions, even despite the validity of the bx → ax 
pathway.26   
  
1.7.6 Secondary fragmentation: internal immonium ions  
 
Scheme 1.7 Immonium ion  
 19  
  
Often MSn spectra also contain immonium ions originating from internal positions along 
the protonated peptide backbone. These internal immonium ions are a result of charge directed 
secondary fragmentation pathways as depicted in Scheme 1.7, originating from the bx – yz 
pathway.26 Elimination of CO from the generated bx ion oxazolone ring results in the formation 
of the ax-1 and immonium ion, while elimination of CO from the generated yz ion results in an 
immonium  ion and/or smaller C-terminal containing yz product ions.
26  
  
1.7.7 Loss of small neutrals  
 
  
 
Scheme 1.8 Ammonia loss  
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Under low energy collision conditions small neutral losses (i.e., ammonia and water) are 
a common subset of charge-directed peptide fragmentations, commonly generating [M + H – 
NH3] 
+, [M + H – H2O] +, [bx – NH3] +, [bx – H2O] +, [yz – NH3] +, and [yz – H2O] + product 
ions.26 Ammonia loss typically occurs from the side chains of Asn, Gln, Arg, and Lys, and is 
particularly abundant in the fragmentation of peptides formed from tryptic digests as Lys or Arg 
occupy the C-terminus.26 Scheme 1.8 depicts ammonia loss from an N-terminal lysine side chain, 
initiated by protonation of the side chain amino group (similarly for Gln and Asn, but followed 
by tautomerization of the protonated Arg guanidine group).26 The N-terminal nitrogen then 
attacks the adjacent carbon causing the loss of ammonium and the formation of a cyclic group 
made up of the long amino acid side chain and N-terminal nitrogen. Lys, Arg, Asn, and Glu 
found at other positions along the peptide backbone can also experience ammonia loss, however 
by nucleophilic attack by the neighboring C-terminal carbonyl oxygen.26  
  
 
 
Scheme 1.9 Water loss  
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Water loss can occur by dehydration at the side chains of Ser, Thr, the carboxylic acid 
group of the Asp and Glu side chains, and the C-terminus.26 C-terminal water loss is depicted in 
Scheme 1.9 beginning with proton migration to the amide oxygen adjacent to the last amino acid 
residue.26 The next steps include the concerted transfer of the proton to the C-terminal hydroxy 
group and release of water, followed by the formation of an oxazolone ring by nucleophilic 
attack of the amide oxygen. Water loss from Asp and Glu positioned at the N-terminus proceeds 
by mobilization of the proton to the side chain hydroxy group and attack on the side-chain 
carboxy carbon center by the N-terminal nitrogen.26 Ser and Thr lose water by protonation of the 
side chain hydroxy group followed by an attack by the adjacent amide oxygen on the adjacent 
side chain carbon forming a stable five- or six-membered ring.26  
  
1.8 Example of direct de novo sequencing  
Generating sequence ions is imperative to the success of de novo peptide sequencing. In 
contrast to high-energy CID which promotes non-sequence ion formation, low-energy CID 
conditions, as those classically used in linear ion trap mass spectrometers, promote sequence ion 
formation and specifically mass spectra rich in a, b, and y-ions.26 Without question, the more 
types of sequence ions present in a mass spectrum enhance de novo efforts. However, a 
straightforward residue-by-residue identification of peptide sequence can be achieved if the full 
y-ion or b-ion series is generated.   
Consider Figure 1.5 depicting a model MS2 spectrum for model protonated precursor 
peptide ion [M+H]+ = [P-E-P-T-I-D-E]+. The mass difference between the model [M+H]+ ion 
and the m/z 654.77 peak is equal to 146.15 u, indicating the mass loss of the amino acid residue 
E + 17 u (the C-terminal hydroxy group) - thus making the m/z 654.77 peak the b6 ion. Similarly, 
 22  
  
the mass difference between the m/z 539.68 ion and b6 ion peak indicates the loss of the next 
amino acid residue, D, and thus the formation of the b5 ion. Continuing this process of 
identification, all the residues and thus, the amino acid sequence can be determined. Additional 
stages of MSn can be used to verify product ion assignments. However, some factors present a 
significant challenge to the effectiveness of de novo peptide sequencing:55   
1. Incorrect assignment of sequence ions  
2. Missing sequence ions, specifically within the b and y series  
3. Crowding of the mass spectrum with non-sequence ions  
4. Presence of isobaric residues (i.e., K/Q and I/L)  
  
Arguably, the most challenging to the de novo approaches to peptide/protein identification is the 
phenomenon of sequence scrambling which can render MSn spectra uninterpretable.  
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Model MSn spectrum  
 
 
  
 
Figure 1.5 Model MSn spectrum. [M+H]+ is the imaginary protonated peptide ion, 
[PEPTIDE]+. The model amino acid depicts, within the yellow box, what portion of the amino 
acid determines the residue mass.   
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1.9 Sequence scrambling  
The structure of b-ions have been identified as linear N-terminus containing fragment ions 
with conserved primary amino acid sequence, terminated by a five or six membered oxazolone 
ring at the C-terminus.26, 68 Recent experiments79-83 strongly suggest that after amide bond 
cleavage a macrocyclic b-ion intermediate can arise through cyclization of the b-ion (Scheme 
1.10).68, 83 The macrocyclic b-ion can then open at various ring positions causing a scrambling 
of the peptide sequence.79-83 As a result, the CID-MSn spectrum at the MS3 stage becomes 
representative of the dissociation of various perturbations of the original peptide sequence, thus 
cloaking its identity. CID-MSn studies of b5–ions YAGFL-NH2, AGFLY-NH2, GFLYA-NH2, 
FLYAG-NH2, LYAGF-NH2, and cyclo-YAGFL performed by Bleiholder et al. have 
demonstrated that these different peptides of similar amino acid makeup yield indistinguishable 
spectra.84 The indistinguishable fragmentation patterns are contrary to the driving power of MSn 
based sequencing methods that rest on each peptide sequence generating a unique mass spectrum 
upon fragmentation.   
The potential impact of sequence scrambled product ions on automated/database 
peptide/protein identification (specifically the Mascot software) has been studied for a small set 
of model tryptic peptides by Saminathan et al.85 These investigations determined “scrambled” 
ions had apparently little effect on Mascot match scoring when compared to database searching 
without “scrambled” ions.85 However, it is important to distinguish the critically negative effect 
of sequence scrambling is likely most observable at MS3 and higher tandem stages. A potentially 
exhaustive analysis of a more extensive data set is likely required to assess the impact on 
database searching. Additionally, the direct effect scrambling has on the de novo sequencing of 
novel and lesser investigated peptides/proteins is more prevalent, as the de novo method relies 
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on direct interpretation of sequence ion m/z peaks – which consequently are indistinguishable 
from “scrambled” ion peaks for unknown sequence.    
 
Scheme 1.10 Sequence scrambling   
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1.10 Enhancing de novo peptide sequencing  
From a bioanalytical viewpoint, efforts to enhance MSn de novo peptide sequencing should 
seek to:  
1. Identify the N- and/or C- terminal amino acid  
2. Reduce or eliminate the effects of sequence scrambling to provide unambiguous 
MSn sequencing  
3. Increase sequence coverage, sequence ions as a collective and/or the full series of 
b and/or y ions  
4. Reduce the number of uninformative non-sequence ions for enhanced  
interpretability  
5. Distinguish between isobaric residues  
6. Advance the understanding of the dissociation chemistry involved   
  
De novo techniques that succeed in addressing even some of the above points will afford 
more reliable peptide sequence assignments, as well as possible avenues to better de novo 
sequencing software. As CID-MSn based techniques will likely continue to remain the most 
critical tools for peptide and protein identification in proteomics, maximizing its effectiveness 
and underlining chemistry involved is necessary for progressing the field. Though no one method 
may succeed at addressing each concern, complementary techniques must be sought to facilitate 
improved bioinformatics. It is the goal of the research presented in this document to address the 
central scientific problem of enhancing de novo peptide sequencing by investigating peptide 
derivatization and metal cationization techqniques86-88 for: elimination of sequence scrambling 
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and improved sequence coverage. Explicitly the aims of this research to advance efforts to 
enhance de novo peptide sequencing methods were to:  
  
• N-terminally modify the common research peptide leu-enkephalin ([YGGFL + H]+) to make 
a protonated peptide-imine and observe the CID-MSn spectra for sequence scrambling and 
sequence ion formation  
• Correspondingly, N-terminally modify small protonated peptides to create protonated 
peptide-imines and evaluate each CID-MSn spectrum for product ion formation characteristic 
to the modification  
• Identify the observed novel product ion generated from CID of protonated N-terminal 
peptide-imines presumed to generate from the elimination of the N-terminal amino acid 
residue mass  
• Investigate the affect the N-terminal modification structure has on product ion formation and 
product ion intensity of protonated peptide-imines  
• Evaluate the CID-MSn spectra of metal-cationized N-terminal peptide-imines to survey 
metal-cationization of the modified peptides as an additional technique to mitigate sequence 
scrambling and promote sequence ion generation  
  
1.10.1 Metal-cationization  
Cationization of peptides and proteins is the most commonly used ionization approach for 
CID-MSn sequencing methods, mainly by protonation.89, 90 However, determining the amino 
acid sequence for protonated peptides is not particularly intuitive in practice, as the sequence 
ions that contain the N- and C-terminal amino acids are typically unknown before analysis. Thus, 
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additional sequence information can be invaluable as supplemental to the mass analysis of 
protonated peptides. In part to fulfill this need and address the desire to identify and understand 
intrinsic metal binding sites, alkali and transition metals have been used as alternative peptide 
cationization reagents.90-94  
In contrast to protonated peptides, the CID fragmentation chemistry of alkali metal-
cationized peptides has been proposed to be predominately charge-remote, involving the binding 
of the metal ion to amide carbonyl atoms or the deprotonated C-terminal carboxylic acid.92, 95-98 
Nevertheless, dissociation of metal-cationized peptides commonly produce the bxH, ax-H, and 
yz-H sequence ions, as well as a prominent b-ion derivative, [bx + OH + metal]
+ (Scheme 1.11).87, 
92, 94 Multistage MSn experiments of [bx + OH + metal]
+ have demonstrated complete C-side de 
novo sequencing capabilities as the C-terminal hydroxyl group is transferred to the adjacent 
amino acid in the sequence followed by the subsequent loss of the C-terminal amino acid residue 
mass.79, 92, 99 The resulting metal-cationized peptide, lacking the original C-terminal amino acid, 
can then be used to identify the next amino acid in the sequence by the same C-terminal 
mechanism. Similarly, the [bn + OH + metal]
+ ion has been observed for silver-cationized 
peptides.95, 100 However, an understanding of both alkali- and silver-cationized peptide 
dissociation chemistry remain currently limited for widespread use or integration into 
sequencing software platforms.  
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Scheme 1.11 Charge-remote [bx+OH]
+ pathway. Cat = metal cation  
  
1.10.2 Peptide derivatization  
Peptide sequence coverage (the percent of peptide sequence covered by identified 
product/sequence ions) is arguably the most crucial aspect of successful peptide de novo 
sequencing. However, in practice, complete interpretation of protonated peptide MSn mass 
spectra is often hard to achieve commonly due to the absence of the b1-ion, which identifies the 
N-terminal amino acid.101 Considerable importance is conferred on accurate N-terminal amino 
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acid identification including but not limited to confirming predicted termini of individual 
biological or pharmaceutical proteins, and to study proteolysis in dynamic living systems.15, 102  
N-terminal tagging and derivatization strategies, such as acetylation, have demonstrated 
N-terminal amino acid identification capabilities.103-105 Additionally, several studies have 
demonstrated conclusively that acetylation at the N-terminus eliminates sequence scrambling29, 
83 presumably because the nucleophilic amino group implicated in the cyclization reaction is 
functionalized. However, large scale use of specific N-terminal derivatization as a technique for 
peptide/protein sequencing would require a comprehensive understanding of the fragmentation 
chemistry the modification induces. The remainder of this work, therefore, seeks out to discuss 
the gas phase methods and observations of an investigation into the dissociation behavior 
(fragmentation pattern) caused from N-terminal amine to imine (Schiff base) peptide 
modification.  
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CHAPTER 2  
TECHNIQUES: GAS PHASE ANALYSIS OF PEPTIDES AND 
PROTEINS  
2.1 Mass Spectrometry  
Mass spectrometry (MS) is currently the principal method of analysis for peptide and 
protein characterization and quantification superseding methods such as Edman degradation, N-
terminal amino acid analysis, and ultracentrifugation.106 Ionization followed by mass analysis of 
simple to complex peptide/protein solutions provide a swift determination of molecular mass 
with high mass accuracy and sensitivity, asserting the dominance of mass spectrometric methods 
in the field. Though mass spectrometers may vary from instrument to instrument, be it 
manufactured by a major company or home-built/modified in the lab, the essential components 
that constitute these indispensable tools remain the same (Figure 2.1) as well as the general 
process:   
(1) From the sample of interest, the ionization source generates ions having a mass m 
and total charge q = ze, where z is the charge number and e the elementary charge constant 
(1.6021766208 x 10-19 C).107 The ions obtain a kinetic energy KE  (Equation 2.1) equal to the 
product of the ion charge and the electric potential Vs, produced from the applied electric field 
(acceleration voltage).107  
Equation 2.1                  𝐾𝐸 = 
𝑚𝑣2
2
 = 𝑞𝑉𝑠 = 𝑧𝑒𝑉𝑠 , where v = velocity  
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(2) As the ions emerge from the ionization source they are extracted, focused, and 
accelerated into an ion beam directed toward the mass analyzer(s) via several ion lenses 
positioned just after the source and along the ion path.108 In a two mass analyzer scheme,  static 
or dynamic electric and magnetic fields separate ions in the beam according to their mass-to-
charge ratio (m/z). These fields are combined or used independently, depending on the type of 
analyzer.107, 108 In this way, the ions can be detected or selected for fragmentation. If fragmented, 
the emerging fragment ions are separated by the second mass analyzer and focused toward the 
detector.107   
(3) Detection of the ions and measurement of their abundance is achieved by 
converting the ions into electrical signals that are processed by a computer program. The 
resulting mass spectrum is generated by plotting the m/z values along the x-axis and ion 
abundance along the y-axis.107, 108   
  
The figures of merit attributed to the type of mass analyzer (Table 2.1), along with characteristics 
such as the ionization source and method of fragmentation culminate into a variety of mass 
spectrometers ranging in experimental allure. The following sections will briefly discuss the 
components used in the research of this dissertation.   
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General Mass Spectrometer Schematic  
  
 
Figure 2.1 General Mass Spectrometer Schematic. The blue tags represent 
instrumentation/hardware, and the black tag represents software.  
  
  
Typical Mass Analyzer Characteristics  
  
 
Table 2.1. Typical Mass Spectrometer Characteristics. a Full width at half maximum (FWHM), 
describes the mass resolving power describes as, M/ΔM, where M is the mass of the singly charged 
ions that make up a single peak, and ΔM the width of the peak at %50 of its height; b linear dynamic 
range refers to the range over which the ion signal is directly proportional to the analyte 
concentration; c scan rate referred to the number of scans per second possible over the m/z range 
while satisfying the mass resolution; d MS/MS is an abbreviation for tandem mass spectrometry 
indicating only two stages of mass analysis, n corresponds to stages > 2.10  
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2.2 Electrospray ionization  
Electrospray ionization (ESI) is an ionization method first investigated by Malcolm Dole 
but advanced in the late 1980s when Fenn et al110, 109 obtained multiply charged ions from 
proteins, subsequently allowing their molecular weight to be determined by instruments with 
low mass range limits (>2000 u). The process begins as the sample solution is introduced to the 
ion source through a metal needle connected either to a syringe pump or the exit of a liquid 
chromatography column. As the solution passes through the capillary tube at a flow rate typically 
between 1-15 µL/min, a strong electric field (on the order of 106 V/m) is produced at the needle 
tip by applying a potential difference of 2-6 kV (Figure 2.2).112-116 Consequently, charge 
accumulation is induced on the surface of the analyte resulting in highly charged droplets as the 
solution is being sprayed.107, 111, 117, 118 The spray transitions into a fine mist assisted by a sheath 
gas (generally nitrogen) injected inner coaxially at a low flow rate.107, 111, 117 The auxiliary gas, 
an outer coaxial nebulizing gas, aids in evaporating the solution.107, 111, 117, 118  
As the solvent contained in the droplets evaporate, the shrinkage causes the charge per unit 
volume to increase.107, 118 The strong applied electric field and the accumulation of charge 
elongates the shape of the droplets to that of cone known as the Taylor cone.118 Smaller droplets 
emerge (Coulombic explosion) as the repulsive forces between the accumulated charges on the 
droplet surface become equal to or higher than the droplet surface tension, also known as the 
Rayleigh limit.107, 117 Decomposition below the Rayleigh limit may also occur for droplets 
formed at the ESI needle tip mechanically deformed by the applied electric field.107, 118 By either 
means, these small highly charged droplets continue to lose solvent by evaporation as they pass 
through a curtain of heated inert gas (nitrogen), or through a heated capillary producing further 
droplet generations until the electric field on their surface becomes large enough for desorption 
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of ions from the surface.118 As aforementioned, ESI of large biological macromolecules such as 
proteins tend to form multiply charged ions through protonation [M + zH]z+, typically one charge 
per thousand Daltons unless very few basic amino acids.11 Small molecules such as peptides less 
than a thousand Daltons tend to produce monocharged ions [M + H]+ which are focused toward 
the mass analyzer by skimmers and ion lenses.11  
  
Electrospray ionization (ESI)   
 
  
 
Figure 2.2 Electrospray ionization.107, 112-116   
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2.3 Mass analyzer   
2.3.1 Introduction  
Mass spectrometers are typically distinguished by the mass analyzer(s) it contains – the 
instrument that measures the mass-to-charge ratio of gaseous ions generating the mass spectrum. 
Regarding MS-based proteomics, mass spectrometry should be considered not just as a method 
for discovery but rather a vast field consisting of processes and instruments that differ by, and 
best lend themselves to a specific question. Regarding proteomics, some essential factors to 
consider before MS studies include the instrument sensitivity, fragmentation method (including 
multi-stage capabilities), and the overall analysis strategy.108, 119  
Until the recent invention of the Orbitrap,120 the affordability and lab space requirement 
of spectrometers capable of favorable, high-resolution mass spectrometry (HRMS, resolution = 
0.01 – 0.001 Da) was out of reach for many laboratories.119, 121, 122 Thus, low-resolution mass 
spectrometry (LRMS, resolution = 1 – 0.1 Da) became the dominating mass data collection 
method for early proteomics and the peptide/protein databases.119, 121, 122 Consequently, for its 
general user-friendliness, relative affordability, “desk-space” size, high sensitivity, rapid speed 
of analysis, and multistage fragmentation capabilities108, 119 the mass spectral data collected in 
this research was primarily obtained using an LRMS instrument, the linear ion trap (LIT) mass 
spectrometer, more specifically the Thermo Fischer Scientific LTQ-XL. The balance of this 
section will discuss the operation of the LIT.   
2.3.2 Linear ion trap   
Generally, mass analyzers utilize static and dynamic electromagnetic fields to separate 
gaseous ions based on the m/z values.123 The fundamental difference between mass analyzers 
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rests on how these fields are used to achieve separation. In the case of ion trap mass analyzers, 
separation is based on the same principles employed in quadrupole analyzers – where ion 
trajectory stability in oscillating electromagnetic fields is manipulated by applying electric 
currents at varying amplitudes.107, 123 The two types of current are direct current (DC) consisting 
of electric charge flowing in only one direction and alternating current (AC) which allows charge 
to change direction periodically.107, 123 Classically, ion traps are composed of four rod-shaped 
electrodes to which DC and AC are applied.107  
Different conformations of the basic structure give rise to different types of ion traps with 
their own set of capabilities. Three-dimensional traps - also known as Paul ion traps (Figure 
2.3a) - are configured as if each of the four rods of a quadrupole ion trap is “bent in on itself,” 
having two ellipsoid end cap electrodes (upper and lower) and a central circular electrode.107, 108 
Within 3D ion traps, the ions experience electromagnetic forces in the radial (x and y) and the 
axial dimensions (z), overlapping direct (DC) and alternative (AC) potentials to tightly confine 
ions of all masses.107, 108, 123 Restricted in this 3D trajectory, ions of a given mass are expelled 
from the trap to the detector by applying resonant frequency (radio range, 3kHz – 300 GHz) 
along the z-axis, resulting in a mass spectrum.108, 123   
On the other hand, two-dimensional ion traps are constructed with four hyperbolic rods 
positioned adjacently and cut into three sections, thus allowing for greater ion capacity/storage 
spread out across the z-axis when compared to 3D traps (Figure 2.3b).107, 123, 124  Electromagnetic 
force in 2D ion traps is applied only in the x and y dimensions by AC potentials at a 
radiofrequency voltage to each rod pair with equal amplitude but opposite sign (known as the 
“main RF”, up to ± 5kV, 1 MHz) to confine ions radially, and by DC potentials applied to each 
sectioned portion to confine ions axially.108, 123, 124 It is important to note that the “LIT” 
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nomenclature is used in literature at times to denote the linear entrance and exit path of ions 
entering the trap as with 3D traps, as well as to denote an elongated trapping space, and/or lack 
of an axial (z) force as with 2D traps. For clarity, the 2D distinction will be applied when using 
the LIT abbreviation for the remainder of the discussion of the ion trap functionality. 
Additionally, the Thermo Fischer LTQ-XL instrument used in this work is a 2D linear ion trap.  
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Ion Traps  
  
a) 3D ion 
trap  
b) 2D ion 
trap  
  
 
Figure 2.3 Ion traps. a) 3D ion trap. Direct (DC) and alternating (AC) potentials are applied in 
the radial (x and y) and the axial (z) dimensions to tightly confine ions.107, 108 b) 2D linear ion trap 
(LIT) with radial ejection. Only AC potentials are applied in the radial dimensions (Main RF), 
while DC potentials are applied in the axial dimension.107, 123, 124  
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While confined inside the LIT ions move in a “spiral type” motion about the trap dependent 
on the amount of force applied by the main RF and therefore proportional to its amplitude and 
the mass of the ion, where lighter ions move about more than heavier ones.107 Ions are ejected 
from the trap to the detector radially through parallel slits cut into a pair of the quadrupolar rods 
opposite each other known as the “exit rods”.108, 123, 124 This action is achieved by applying an 
additional AC to each exit rod equal in amplitude but opposite in phase.124 As the frequency of 
the trapped ion motion induced by the main RF and dependent upon the ion m/z begins to 
resonate with the frequency of the exit rod AC the trapped ion will begin to eject from the trap 
in a process known as resonance ejection.107, 108, 123, 124 Thus, the mass spectrum is obtained by 
selecting the “scan” function which corresponds to steadily ramping up the main RF so that the 
ions in the trap, according to their m/z, sequentially enter resonance with the exit rods AC and 
exit to the detector.108, 123, 124  
  
2.4 Tandem mass spectrometry  
The mass analysis discussed above is descriptive of one mass spectrometric event or stage 
whose resulting mass spectrum is often denoted as MS or MS1. Arguably, however, the most 
powerful function of the LIT is its ability to perform multiple stages of mass analysis known as 
tandem mass spectrometry. Tandem MS experiments consist of isolating a precursor ion (𝑚𝑝+) 
within the ion trap, that then undergoes dissociation to yield product ions (𝑚𝑓+) and neutral 
fragments:68, 107, 108, 123, 124  
  
Equation 2.2                             𝑚𝑝+ → 𝑚𝑓+ + 𝑚𝑛𝑒𝑢𝑡𝑟𝑎𝑙  
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Regarding peptide sequencing, product ions generated from peptide precursor ions are 
used to piece together the peptides amino acid sequence. Abbreviations used to denote tandem 
MS experiments include MS/MS, which fundamentally indicates at least two stages of mass 
analysis. However, the abbreviation MSn more accurately symbolizes multiple stages of mass 
analysis where n (i.e., 1, 2, 3…) is the number of stages or generations of ions analyzed.   
An important performance-based MSn distinction to note is between tandem-in-space 
(Figure 2.4a) and tandem-in-time mass analysis (Figure 2.4b). Tandem-in-space analysis 
corresponds to the restriction of mass analysis stages to the number of successive mass analyzers 
the instrument contains.107 Tandem-in-time (Figure 2.4b) analysis corresponds to the processes 
of consecutive mass analyses occurring in the same physical space allowing for many stages of 
analysis.107 Specifically, tandem-in-time MSn corresponds to the tandem function of the LIT. 
The process begins with the completion of the first MS stage, which from the pool of m/z values 
determined an ion of interest (precursor ion) is isolated within the ion trap starting the MSn 
cycle.107 This cycle can be broken down into four operations:  
(1) Precursor ion isolation  
(2) Fragmentation   
(3) Mass Analysis of product ions (described above)  
(4) Selection and isolation of a new precursor ion (i.e., repeating step 1)  
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Tandem Mass Spectrometry  
 
  
 
Figure 2.4 Tandem Mass Spectrometry. a) Tandem-in-space vs. tandem-in-time. b) The general 
operation of tandem-in-time mass spectrometry using a linear ion trap.  
  
  
b)   
a)   
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Isolation is achieved by applying a broadband waveform AC voltage to the exit rods where 
all the frequencies resonant with trapped ions motion are present while excluding the frequency 
of the ion to be isolated.108, 123, 124 The ion isolation waveform voltage coupled with the main RF 
voltage ejects all the ions except the ion for isolation from the trap. Once isolated, the trapped 
ion can undergo fragmentation.  
  
2.4.1 Fragmentation by collision-induced dissociation  
During both MS and MSn experiments, helium gas is bled into the mass analyzer cavity 
with two functions, as a damping/buffer gas and a collisional gas.107, 108 As a buffer gas, helium 
acts to enhance the instrument sensitivity and mass resolution by reducing the kinetic energy of 
the ions entering the mass analyzer, allowing the main RF to trap them efficiently.107 While in 
the mass analyzer cavity, collisions with the helium gas slow the kinetic energy of the ions. The 
result is a steady-state amplitude of the ion’s oscillation and thus a focusing of the ion ejection 
time for more resolved detection.108, 123, 124 As a collisional gas, the energetic collisions between 
the precursor ion and the helium gas result in the fragmentation of the precursor ion into one or 
more product ions, a process known as collision-induced dissociation (CID).   
CID is the most common form of fragmentation in linear ion traps and for fragmenting 
peptide ions.107 During this process, a resonance excitation AC voltage is applied to the exit rods 
causing the trapped precursor ion to gain more kinetic energy as it oscillates about the collision 
cell (i.e., the ion trap in LIT mass spectrometers).68, 124 The ions are driven into the helium gas, 
causing many energetic collisions as it continues to oscillate around the collision cell (Figure 
2.5).68, 107 The collision between the precursor ion and the helium target is a very fast step (10-14 
– 10-16s) coinciding with bond vibrational periods, during which the translational kinetic energy 
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is converted to the internal vibrational energy of the ion.107 This energy is then distributed into 
the molecules vibrational modes (non-linear, 3N – 6, where N is the number of atoms).107, 125 
Many of these inelastic collisions (tens – thousands) cause the ions to become vibrationally 
excited/activated until the energy threshold for dissociation (the activation energy for a particular 
product ion to be formed, Eo) is surpassed leading to fragmentation along the peptide 
backbone.68, 108, 124, 125  
  
Collision Induced Dissociation (CID)  
 
  
 
Figure 2.5 Collision-induced dissociation (CID). During the first step (1) an excitation voltage 
is applied to the ion trap exit rods causing the trapped, oscillating ions to gain kinetic energy; the 
second step (2) involves many energetic, inelastic collisions between the ion and the buffer gas 
(i.e., helium) resulting in vibrational activation of the precursor ions; step (3) involves the 
fragmentation of the activated precursor ions, beyond the dissociation threshold, into smaller 
fragment ions.  
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The extent of fragmentation and product ion formation of protonated peptide ions under 
these conditions are dependent on a few factors including,107  
(1) Activation time – the time precursor ions spend experiencing collisions  
(2) Excitation AC voltage  
(3) Precursor ion dissociation probability as governed by the theory of quasi  
equilibrium (QET)  
  
At a lengthened activation time, more collisions occur between the precursor ion and the 
collision gas, resulting in the transfer of more energy into the ions’ vibrational modes.125 The 
transferable energy at each collision also increases by raising the user-defined excitation AC 
voltage, i.e., the normalized collision energy (NCE).125 At higher voltages, the kinetic energy of 
the ions oscillating in the trap increases causing each impact with the collision gas to be more 
energetic.125 Either by changing the activation time or changing the NCE, the amount of energy 
transferred into an ion can be controlled and thereby the fragmentation rate;126 presumably, the 
dissociation threshold energy (stability), and the energetic and kinetic dependence on 
fragmentation or formation of an ion can also be deduced. Experiments monitoring precursor 
ion dissociation or product ion formation as a function of increasing NCE or activation time are 
known as “energy-resolved” and “time-resolved” respectively.  
QET is a widely accepted approach that describes the rate of unimolecular decompositions 
of ions with excess internal energy (Eex) under mass spectrometric conditions (i.e., under high 
vacuum), originally adapted to describe electron impact (EI) ionization.107, 127-129 This theory 
strongly correlates ion internal energy distribution, like that resulting from CID, to the rate 
constants of ion dissociation in the gas phase.107 Several postulates govern QET: 107, 128-130  
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(1) All the degrees of freedom of the gaseous molecule participate in the energy  
distribution with the same probability.  
(2) The rate of dissociation is small compared to the rate of the randomized excitation  
energy redistribution among all the ions’ internal modes.  
(3) The probabilities that the randomized energy distribution becomes concentrated  
explicitly in ways that give rise to several activated complex configurations (for 
non-linear ions) determine the rate of dissociation.   
(4) The observed dissociation products result from a series of competitive  and 
consecutive irreversible reaction pathways governed by the Eo required to form its 
products.  
  
By these conditions, the fragmentation pathways of an isolated ion are dependent upon the 
structure of the ion and the amount of energy deposited during activation and not the method of 
ion activation itself.107, 128-130 Consequently, this allows QET not only to be applied to mass 
spectra produce from EI but also CID. An illustration of QET is depicted by the Wahrhaftig 
diagram (Figure 2.6), where the x-axis represents the internal energy of the theoretical ion 
ABCD+.130 The upper diagram y-axis indicates the probability of a product ion being formed 
while the lower diagram y-axis indicates the logarithmic dissociation rate constant.   
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Warhaftig Diagram  
 
  
 
Figure 2.6 Warhaftig Diagram. Upper diagram. The probability a specific hypothetical ion is 
generated at a given amount of deposited internal energy is plotted on the surface of the bell curve. 
Lower Diagram. The logarithmic rate constant for product ion formation is plotted as a function 
of internal energy. Es/ (stable ion), Em/ (metastable ion), and Eo correspond to the energy threshold 
(activation energy) required for an ion/pathway to persist. The red (loose ion complex) and blue 
(tight ion complex) lines depict the effect structure has on the rate constants as well as represent 
the thermodynamics of each pathway, where AD+ formation is energetically favored, and AB+ 
kinetically favored.130  
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2.4.2 Fragmentation by infrared multiple photon dissociation  
Though an indispensable tool for identifying peptide/protein sequence, the m/z data 
generated from tandem mass spectrometry do not explicitly offer any product ion structural or 
conformational information. Determining product ion structure, however, not only validates 
product ion assignments but also aids in deducing the fragmentation pathway that generated the 
ion for a better understanding of the fragmentation chemistry. To this end, infrared multiple 
photon dissociation (IRMPD) spectroscopy has proven to be a valued technique that provides 
direct structural insight for gas phase peptide ions.68, 131-136  
Activation by IRMPD occurs when trapped gaseous ions (by an ion trap or ICR cell) are 
irradiated with photons generated from a tunable IR laser.107, 133 Absorption of a photon occurs 
when the laser frequency producing the photons matches a vibrational mode of the precursor 
ion, which is followed by rapid intramolecular vibrational distribution (IVR) over all the 
vibrational modes of the ion.107, 133 By IVR the energy of each photon dissipates before the ion 
absorbs the next photon.107, 133 As multiple photons are absorbed the internal energy of the ion 
increases toward a dissociation threshold (Eo) to excess, leading to product ions in a “slow 
heating” process like CID that can be described by QET, and depicted by the following 
mechanism:107, 133  
 
Equation 2.3                          𝑚𝑝
+  
𝑛ℎ𝑣
→  𝑚𝑝
+≠  
𝑘𝑑𝑖𝑠𝑠
→   𝑚𝑓
+  +  𝑚𝑛𝑒𝑢𝑡𝑟𝑎𝑙      
  
where 𝑚𝑝
+≠  is the activated precursor ion, hv the photon energy, n the number of absorbed 
photons, and kdiss the rate constant for photodissociation. This type of resonant absorption of 
photons produces a frequency-dependent fragmentation signal.133 IR-active spectra are 
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generated by plotting frequency on the x-axis and product ion intensities in terms of 
fragmentation yield (Equation 2.4) on the y-axis:68, 133-136  
 
 Equation 2.4  
∑𝑓𝑟𝑎𝑔𝑚𝑒𝑛𝑡 𝑖𝑜𝑛 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑖𝑒𝑠
∑𝑓𝑟𝑎𝑔𝑚𝑒𝑛𝑡 𝑖𝑜𝑛 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑖𝑒𝑠 + 𝑝𝑎𝑟𝑒𝑛𝑡 𝑖𝑜𝑛 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦
                     
  
 
The resulting IR absorption bands can be used to determine the structure of the precursor ion or 
compared to the experimental or theoretical IR spectra of ions with a known structure for 
identification.  
  
2.4.3 Theoretical vibrational IR spectra  
Theoretical vibrational spectra can be obtained for proposed peptide ion sequence by 
density functional theory (DFT) calculations. Introduced in 1964 by Kohn and Hohenberg, DFT 
demonstrates that ground state electronic energy can be determined by electron density.137 
Generation of theoretical IR spectra is accomplished by performing computational geometry 
optimization and frequency calculations. The process of geometry optimization consists of 
computing local and global minimizers of the molecules potential energy surface (PES) - the 
molecules potential energy as a function of its atomic positions in space (Figure 2.7).137-139 The 
atoms are moved little by little, and at each perturbation the energy is calculated.140 The lowest 
energy is obtained at the optimized geometry, considered a stationary point on the PES, where 
the net-inter-atomic force on each atom is acceptably close to or equal to zero minimizing the 
strain on the given system.137, 140 The low-energy, optimized geometry often corresponds to the 
intrinsic structure of the molecule from which geometry minima and vibrational frequencies are 
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calculated and used to produce a theoretical vibrational spectrum.140 The success of 
computational vibrational spectra has been shown for small polypeptides by Gaigot et al. with 
an excellent agreement to spectra obtained experimentally by IRMPD.141-143  
  
Potential Energy Surface  
  
 
  
 
Figure 2.7 Potential energy surface. DFT geometry optimization protocols sample the surface 
for energy minima, at which the most stable geometries exist. A saddle point is a minimum on one 
path along the surface and a maximum along another.137-139   
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CHAPTER 3  
METHODS  
3.1 N-terminal amine to imine derivatization  
3.1.1 Sample preparation  
The peptides GG, GGG, GGA, LGG, FGG, YGGFL, and the aldehydes benzaldehyde, m-
methoxybenzaldehyde, and p-methoxybenzaldehyde were purchased from Sigma Aldrich (St. 
Louis, MO, USA). The peptide VGG was purchased from Bachem (Bubendorf, Switzerland). 
The peptides YGG, SGG, and TGG were purchased from Chem-Impex International Inc. (Wood 
Dale, Il, USA). The peptide AGG was purchased from TCI-America (Portland, OR, USA) and 
the aldehydes salicylaldehyde, o-methoxybenzaldehyde, m-hydroxybenzaldehyde, and p-
hydroxybenzaldehyde were purchased from Alpha Aesar (Ward Hill, Ma, USA). All peptides 
were used as received with no further purification. Peptide imines were produced by reacting the 
selected peptide with an aldehyde (1:1 mole ratio) in methanol for 2-6 h at 37 °C. The reaction 
mixture was diluted with a 50:50 solution of methanol/water. The expected mass shift observed 
in the mass spectra (corresponding to the modifier used) confirmed the successful modification 
of the peptides by Schiff base (condensation) reaction (Scheme 3.1). The final peptide 
concentrations for ESI-MS studies were ~10-4 M. Protonated peptide-imines, [M+H]+ ions, were 
generated by acidifying peptide solutions with 10 µL of 1% acetic acid in water and vaporized 
to the gas phase using ESI.  
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Scheme 3.1 Imine-derivatization (Schiff base)  
  
3.1.2 CID experiments  
Multiple-stage CID experiments were conducted on a ThermoScientific LTQ-XL linear 
ion trap mass spectrometer (ThermoScientific, San Jose, Ca, USA). The acidified peptide-imine 
solutions were infused into the ESI-MS instrument using a syringe pump at a flow rate of 5 
µL/min. The atmospheric pressure ionization stack settings for the LCQ (e.g., lens voltages, 
quadrupole, and octupole voltage offsets) were optimized in the positive ion mode to produce 
the maximum [M+H]+ transmission to the ion trap mass analyzer using the auto-tune function 
within the LTQ Tune package. Following the instrument tune, the spray needle voltage was 
maintained at +5kV, the Ns sheath gas flow at ten units (arbitrary for the ThermoScientific 
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instruments) and the capillary temperature held at 200 °C.  Helium was used as the bath gas for 
enhanced trapping efficiency and as the ion trap collision gas.  
For the initial CID (MS/MS) experiments the protonated peptide-imine ions, [M+H]+ were 
isolated using an isolation width of 1.0-1.5 mass-to-charge units that reflected the best 
compromise between high [M+H]+ abundance and single isotopic peak isolation. The (mass) 
normalized collision energy (NCE, defined by ThermoScientific) was set between 20% and 25%, 
which corresponds roughly to 0.80-0.99 V with the current instrument calibration used in this 
study. The activation Q (defines the frequency of the applied radio frequency potential) was set 
to 0.30, and the activation time set to 30 ms. The mass spectra obtained represented an 
accumulation and averaging of at least 30 isolation, dissociation, and detection steps. Following 
CID stages (MSn) were performed through the isolation of [M+H]+ product ions, and subsequent 
NCE applied, inducing fragmentation.   
  
3.1.3 CID energy/time-resolved experiments  
For the energy/time-resolved experiments, [M+H]+ ions were isolated using an isolation 
width 1.0-1.5 m/z units. CID (MS/MS) normalized collision energies ranging from zero to 50  
(0-2.5 V) were applied sequentially to the fragmentation of [M+H]+ to 0.0-10% ion abundance. 
Over the NCE range the activation time (corresponding to the time at each data acquisition step 
[M+H]+ is held in the ion trap during CID) was set to 10, 100, and 1000 ms representing 3 
separate time-resolved stages, conducting data acquisition at each NCE (at least 30 isolation, 
dissociation, and detection steps). The activation Q was set to 0.30. Each activation time trial 
was repeated in triplicate, and the average obtained.  
  
 67  
  
3.2 Characterization of N-terminal amino acid elimination from protonated 
peptide-imines  
3.2.1 Sample preparation  
Peptides GG, GGG, AGG, AGGG, VAAF, YGGFL, and the aldehyde benzaldehyde were 
purchased from Sigma Aldrich (St. Louis, MO. The peptide PGG was purchased from Bachem 
(Bubendorf, Switzerland). The aldehyde salicylaldehyde and o-methoxybenzaldehyde were 
purchased from Alfa Aesar (Ward Hill, Ma, USA). The peptides were used as received without 
further purification. Peptide imines were produced by reacting peptides with salicylaldehyde (1:1 
mole ratio) in methanol for 2-6 h at 37 °C. The reaction mixture was then diluted with a 50:50 
solution of methanol/water and then acidified with 10 µL of 1% acetic acid in water. 
Confirmation of peptide modification was achieved by observation of the corresponding 
derivatization mass shift, the expected change due to the Schiff base reaction. The final peptide 
concentration for ESI-MS and IRMPD studies were ~ 10-4 M.  
  
3.2.2 CID experiments  
(See section 3.1.2)  
  
3.2.3 ESI FT-ICR mass spectrometry  
Previously established methods were used for the generation of ions and the subsequent 
collection of IRMPD spectra,133 a brief overview has been provided. Ion trapping and mass 
analysis were carried out with a laboratory-built Fourier transform ion cyclotron resonance (FT-
ICR) mass spectrometer,133 equipped with a Micromass Z-spray ESI source positioned inside 
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the magnetic field near the FT-ICR analyzer cell. The instrument was controlled externally by a 
modular ICR data acquisition system (MIDAS) developed at the National High Magnetic Field 
Laboratory (NHMFL) Instrument.133 Operating parameters were optimized to maximize the 
formation of [M+H]+ ions, or b2 ions generated by the in-source CID, and transfer of the species 
to the ICR cell. Dry nitrogen (~80 °C) was used to assist in the desolvation process.  
  
3.2.4 Infrared multiple photon dissociation (IRMPD)  
The experiment apparatus used has been described in detail elsewhere,133 and only a brief 
outline is given here.  These experiments were carried out at the Free Electron Laser for Infrared 
eXperiments (FELIX) facility at Radboud University Nijmegen, Netherlands. The IRMPD 
spectroscopy instrument utilized consists of a Paul-type quadrupole ion trap combined with a 
time-of-flight (TOF) mass spectrometer. To perform IRMPD the [M+H]+ was isolated using an 
ion trap then irradiated with a free electron laser (FEL) infrared pulse. The wavelength of the 
FEL is continuously tunable between 2000 – 40 cm-1 (5 – 250 µm) and the bandwidth can be 
varied between 0.4% and 7% of the central wavelength. To cover this wavelength range, FELIX 
utilizes two lasers, FEL-1, and FEL-2 that work at different electron beam energies, 15 – 25 
MeV and 25 – 45 MeV respectively, covering the ranges of 25 – 250 µm (FEL-1) and 5 – 30 µm 
(FEL-2).  
Additionally, the wavelength range between 2000-3500 cm-1 is accessible by operating 
FELIX on the third harmonic, accomplished by replacing one of the gold-coated cavity mirrors 
with a dielectrically coated mirror. The fragment ions generated were subsequently pulse 
extracted to a TOF mass spectrometer. Note, fragment ions were observed whenever the tunable 
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infrared laser imparted enough energy to induce resonance enhanced multiple photon 
dissociation. The IRMPD spectrum was generated by obtaining the series of [M+H]+ mass 
spectra collected as a function of laser wavelength and then plotting fragmentation yield as a 
function of wavelength. Additionally, IR spectra were obtained by dividing the total fragment 
yield by the total ion signal as the wavelength of FELIX is scanned. Note that the IRMPD process 
induces a vibrational-mode-dependent redshift, which was found to be typically 1.5% for a 
variety of polyaromatic ions.  
  
3.2.5 DFT geometry optimization and frequency calculations  
Geometry optimizations for [oHB=AGG + H]+ and the possible structures resulting from 
the elimination of 71 u  from [oHB=AGG + H]+ were performed using the Gaussian 03 
programs.144 These calculations were completed with the 3-21G* basis set and using the 
commonly employed hybrid B3LYP functional.145-148 The identified minima were then used to 
perform relaxed scans by rotating the dihedral angles along the peptide backbone in three degree 
steps through to 360 degrees. Geometry optimization and frequency calculations for the minima 
identified through these scans were then obtained using the B3LYP functional and the 6-
311+G(d,p) basis set, commonly used for peptide structures in literature.149-151 The computed 
vibrational frequencies were scaled by a factor of 0.98, chosen empirically to generate a 
correlation between the theoretical and experimental IRMPD derived IR spectra.28, 152 
Theoretical IR spectra were generated by plotting the computed intensities as a function of the 
computed and scaled vibrational frequencies.   
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3.3 Metal-cationized peptide-imines   
3.3.1 Sample preparation  
The peptides GGG, YGGFL, and the aldehyde d1-benzaldehyde were purchased from 
Sigma Aldrich (St. Louis, MO, USA). The aldehydes benzaldehyde and o-methoxybenzaldehyde 
were purchased from Alfa Aesar (Ward Hill, MA, USA). The peptide VAAF was purchased 
from Bachem (Bubendorf, Switzerland). The peptide AGG was purchased from TCI-America 
(Portland, OR, USA). All peptides were used as delivered without further purification. Peptide 
imines were generated by reacting peptides with an aldehyde (1:1 mole ratio) in methanol for 2-
6 h at 37 °C. The reaction mixture was diluted with 50:50 methanol/water. The expected mass 
shift resulting from the condensation reaction was used to confirm the successful modification 
of the respective peptides. The final peptide concentrations for ESI-MS studies were ~10-4 M.   
Generation of protonated [M+H]+ ions was promoted by acidifying the modified peptide 
solutions with 10 µL of 1% acetic acid in water. Similarly, metal-cationization ([M+Ag]+) was 
promoted by mixing unacidified peptide solutions with a 1 x 10-4 M solution of AgNO3 in water 
at a 50:50 ratio. [M+H]+ and [M+Ag]+ ions were vaporized into the gas phase by infusing the 
solution to the ESI-MS instrument using the incorporated syringe pump.  
  
3.1.2 CID experiments  
Ion trap multiple-stage CID experiments were conducted on a ThermoScientific LTQXL 
linear ion trap mass spectrometer (Thermo Scientific, San Jose, CA, USA). The atmospheric 
pressure ionization stack settings for the LCQ (e.g., lens voltages, quadrupole, and octupole 
voltage offsets) were optimized for maximum [M+Ag]+ transmission to the ion trap mass 
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analyzer using the auto-tune function within the LTQ Tune program. Following the instrument 
tune, the spray needle voltage was maintained at +5 kV, the N2 sheath gas flow at ten units, and 
the capillary temperature at 200 °C. Helium was used as the buffer gas to improve trapping 
efficiency and as the collision gas for CID experiments. The CID studies (MS/MS and MSn) for 
[M+Ag]+ were performed as described in section 3.1.2. To reduce spectral overcrowding, only 
the 107Ag isotope was isolated.  
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CHAPTER 4  
FRAGMENTATION PATTERN OF PROTONATED, N-
TERMINAL PEPTIDE-IMINES  
4.1 Introduction  
Under low-energy CID conditions classical b ions have been proven to isomerize into 
macrocyclic b-ions through an attack by the N-terminal amine on the C-terminal oxazolone 
ring.26, 68, 79, 83 Dissociation of the macrocyclic b ion leads to ring opening at various amide bonds 
causing the peptides’ primary sequence to be “scrambled,” rendering de novo sequencing efforts 
unsuccessful.79, 83, 84 N-terminal modifications such as acetylation have been shown however to 
reduce or eliminate the pathway that leads to b ion macrocyclization by functionalizing the N-
terminal amine implicated in the cyclization pathway.29, 83 As an alternative, the CID-MS2 
spectra of N-terminal amine to imine derivatized peptides by condensation reaction with 
salicylaldehyde (Sal) (Scheme 3.1) were evaluated for mitigating effects on sequence scrambling 
and to enhance MSn approaches to direct (de novo) peptide identification. N-terminal amine to 
imine (Schiff base) peptide derivatization was hypothesized to eliminate sequence scrambled 
product ions by the functionalization of the N-terminus much like in the way acetylation was 
shown to do. It is important to note, though the Sal abbreviation for salicylaldehyde appears in 
published work, to better distinguish the hydroxy substituent position on the benzyl ring moiety, 
the “oHB” abbreviation has been used in this present document, derived from the 
interchangeable o-Hydroxybenzaldehyde (where o = ortho) nomenclature. Additionally, the “=” 
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symbol, as in [oHB=Peptide + H]+),  has been used to indicate the imine transformation at the 
N-terminus.  
  
4.2 Results and Discussion  
4.2.1 Fragmentation pattern of imine-derivatized leucine-enkephalin  
Protonated leucine-enkephalin (YGGFL) has been widely used as the model peptide in  
fundamental studies of peptide fragmentation.29, 31, 34, 79, 153 Under low energy CID, the dominant 
peaks generated for [YGGFL + H]+ is the b4 and a4 ions at 100% and 75% relative intensity 
respectively (Figure 4.1a). Product ions b3, b2, y3, and y2 were also observed along with peaks 
consistent with the neutral loss of water to form the b5 ion at m/z 538, followed by CO loss to 
form the a5 ion at m/z 510. Rearrangement reactions (i.e., sequence scrambling reactions) for 
protonated YGGFL, leading to the apparent elimination of internal amino acid residues, have 
also been studied and reported by Vachet and coworkers.31, 34 The product ions marked by an 
asterisk at m/z 177, 205, 262, and 380 are resultant of these rearrangement reactions, and 
therefore contain no sequence-specific information.  
Considering the negative influence of sequence scrambled product ions is likely highest at 
MS3 and higher tandem stages, the tandem MS spectrum generated from CID of the protonated 
YGGFL b4 (m/z 425) ion and resulting a4 (m/z 397) ion are shown in Figure 4.1b and Figure 
4.1c, respectively. CID of the b4 ion at m/z 425 (556 MS
2→ 425 MS3→ mass spectrum) produced 
two sequence ions, the a4 and b3 at 100% and less than 2% relative intensity, respectively (Figure 
4.1b). The “scrambled” product ion peak at m/z 262, suggesting a loss of 163 u (Tyr residue 
mass), was also observed. CID of the MS3 generated a4 ion at m/z 397 (m/z 556 MS
2→ 425 MS3→ 
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397 MS
4→ mass spectrum) produced the b3 ion at ≈ 25% relative intensity, with the a3 and b2 ions 
observed at a relative intensity less than 2% (Figure 4.1c). The most abundant peaks were 
observed at m/z values 380 and 323. Peak m/z 380 appeared to be generated from the neutral 
loss of NH3 (17 u) followed by the possible internal elimination of a glycine residue (57 u) to 
create an apparent “scrambled’ product ion at m/z 323. These apparent “scrambled” peaks were 
in addition to the m/z 177, 205, and 265 peaks observed at the MS2 stage of protonated YGGFL, 
saturating the a4 fragmentation pattern with non-sequence-specific product ions and 
demonstrating the sequence scrambling effect continues into later stages of MSn.     
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____________________________________________________________________________ 
Figure 4.1 CID spectrum of a) protonated YGGFL (MS2), b) b4 product ion (MS
3), c) and a4 
product ion (MS4).   
b) 
c) 
a) 
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Compared to the underivatized version, CID of protonated imine-derivatized YGGFL 
([oHB=YGGFL + H]+) generated the full series b type ions (Figure 4.2a). The dominant peak 
observed was the b4 ion, with the b1 and a1 ions observed at a relative intensity less than 2%.  
The product ion peaks indicative of the b5 (m/z 642) and a5 (m/z 614) ions were also observed.  
Interestingly, a product ion peak at m/z 547 was observed corresponding to the formation of a 
[b4 + H2O]
+ ion, indicative of a protonated b4 ion with a classical carboxy terminus. These species 
of ions are generally observed for protonated peptides that contain one or more arginine 
residues,33, 154, 155 or for metal-cationized (Li+, Na+, or Ag+) peptides forming the analogous [bx 
+ OH + Metal]+ species.92, 94, 95, 98, 100, 156-159 Presumably, imine functional group competes 
favorably for the protonating hydrogen positioning the charge at N-terminus and allowing for a 
charge remote pathway similar to Scheme 1.11 to persist at the C-terminus.  
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Figure 4.2 CID spectrum of a) protonated oHB=YGGFL (MS2), b) b4 product ion (MS
3), c) and 
a4 product ion (MS
4) 
a) 
b) 
c) 
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CID of the b4 ion generated from [oHB=YGGFL + H]
+ (m/z 660 MS
2→529 MS3→ mass 
spectrum) produced a fragmentation pattern containing only the a4, b3, and b2 ions (Figure  
4.2b). Subsequent CID of the a4 ion generated from CID of the b4 ion (660 MS
2→529 MS3→501 
4→ mass spectrum) produced the full remaining bx/ax ion series (Figure 4.2c). The b3 ion MS 
was observed as the dominant product ion, followed by the b2 ion at ≈ 10% relative intensity, 
and the a3, a2, b1, and a1 ions at relative intensities less the 5%.   
Expectedly, the internal residue losses as a result of peptide rearrangements (i.e., 
scrambling) observed during multistage CID of protonated underivatized YGGFL were not 
observed for [oHB=YGGFL + H]+. Unexpectedly, the fragmentation pattern of imine-
derivatized YGGFL contained no yz ions. Presumably, the N-terminal imine nitrogen conserved 
along the bx-yz pathway (Scheme 1.1) favorably retains the ionizing proton following the 
cleavage step, promoting b ions in the mass spectrum. Interestingly, CID of [oHB=YGGFL + 
H]+ also generated a more extensive series of N-terminal b and a ions at each tandem stage, 
including the b1 ion. Assumedly, the secondary fragmentation bx-bx-1 and bx-axbx-1 pathways 
(Scheme 1.5 and Scheme 1.6) become more competitive as a result of the apparent elimination 
of the macrocyclic pathways that lead to peptide rearrangements.   
More interestingly, CID of protonated oHB=YGGFL (Figure 4.2a) generated a small peak 
at m/z 497 indicative of losing 163 u, the residue mass of tyrosine (Y). Additionally, at the MS4 
stage, CID of the a4 ion created a peak at m/z 338 also suggesting the loss of 163 u. Assumedly, 
this loss implicates an internal elimination that expels the N-terminal amino acid residue, while 
unexpectedly conserving the imine modification to the rest of the primary sequence.   
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4.2.2 Fragmentation pattern of imine-derivatized tripeptides  
To further probe the general fragmentation pattern of imine modified peptides and the 
apparent N-terminal amino acid elimination, the CID mass spectrum of simple tripeptides with 
the form XGG derivatized by condensation reaction with salicylaldehyde were obtained. The 
CID-MS2 spectrum of underivatized peptides GGG, AGG, VGG, LGG, FGG, YGG –  
increasing in N-terminal sidechain size, and underivatized SGG and TGG – whose N-terminal 
sidechains are implicated in water loss reactions,160 are presented in Figure 4.3. Each spectrum 
revealed a simple fragmentation pattern, characteristically containing b, y, and a-ions. The 
dominate ion generated in each case was the b2 ion, identified by a loss of 75 u (the C-terminal 
residue mass of Gly). The a2 ion identified by a loss of 103 u was also observed for each 
tripeptide at relative intensities less than 4%. The C-terminal containing y2 ion identified by the 
m/z 133 peak was generated by CID of each underivatized peptide, except GGG which generated 
the y1 ion at m/z 75 (Figure 4.3a). CID of protonated LGG (Figure 4.3d), FGG (Figure 4.3g), 
and YGG (Figure 4.3h) generated the a1 ion at approximately 3%, 12%, and 21% relative 
intensities, respectively. The a1-yx pathway (Scheme 1.3) has been implicated in the formation 
of the a1 and corresponding yx ions (e.g., the y2 ion for tripeptides) for small underivatized 
peptides.161   
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Figure 4.3 CID mass spectrum of protonated underivatized a) GGG, b) AGG, c) VGG, d) LGG,  
e) SGG, f) TGG, g) FGG, and h) YGG.     
  
  
  
  
b )   
c )   
d )   
a )   e )   
f )   
g )   
h )   
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Note, the a1 ion formed from protonated GGG, AGG, and SGG fall below the low-mass 
cut off (LCMO) of the LIT. Defined in part by the activation Q, the LMCO can be determined 
by Equation 4.1, where m is the ion mass and 0.908 the RF amplitude necessary to eject ions 
from the trap:162  
  
           Equation 4.1                    LMCO = (m * Q) / 0.908  
  
In the present case, the Q was set at 0.25, the default for the Thermo LTQ-XL, therefore 
determining the LMCO as 52.3 for [GGG + H]+, 56.2 for [AGG + H]+, and 60.6 for [SGG + H]+, 
placing the a1 ion below the limit. Losses of 18 u representing C-terminal H2O loss (Scheme 
1.9),163 and 45 u indicative of eliminating CO and NH3 via a pathway under investigation by 
Bythell et al.,164 were also observed for each peptide.  
The CID-MS2 spectra of GGG, AGG, VGG, LGG, FGG, and YGG imine-derivatized with 
oHB are shown in Figure 4.4. As expected, the a and b ions were observed at m/z values 104 u 
higher than the analogous underivatized versions, indicative of conserving the imine 
modification at the N-terminus. Notably, CID of the imine modified peptides in each case 
generated the full series of bx and ax ions. Notably, imine-derivatization promoted the generation 
of the b1 ion via CID, characteristically absent from the CID spectra of the underivatized 
tripeptides. It has been suggested the lack of an amide oxygen N-terminal to b1 cleavage site 
hinders b1 ion formation via the oxazolone pathway shown in Scheme 1.1 for underivatized 
peptides.165-167 However, the observed b1 ion for imine-derivatized peptides implicates a b1 
pathway despite lacking the conventional nucleophile. A loss of 18 u likely along the C-terminal 
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water loss pathway (Scheme 1.9) forming the b3 ion was also observed for each imine-
derivatized peptide.  
CID of each oHB tripeptide generated the [b2 + H2O]
+ ion identified by the peak 18 u 
higher than the corresponding b2 ion. Interestingly, the [b1 + H2O]
+ ion was also observed for 
oHB derivatized AGG at m/z 194 (Figure 4.4b), VGG at m/z 222 (Figure 4.4c), FGG at m/z 270 
(Figure 4.4e), and YGG at m/z 286 (Figure 4.4d). In contrast, the [bx + H2O]
+ ion corresponding 
to b ions smaller than b4 was not observed for the CID of the imine-derivatized pentapeptide 
oHB=YGGFL (Figure 4.2a). More interestingly, CID of the derivatized tripeptides produced 
several novel fragment ions, including the supposed N-terminal amino acid elimination ion peak, 
termed the “y-double dagger” ion (yǂ). In contrast to the small peak observed for [oHB=YGGFL 
+ H]+, the yǂ ion was observed as the dominate ion peak at m/z 237 for protonated oHB=AGG (- 
71 u, Figure 4.4b), oHB=VGG (- 99 u, Figure 4.4c), oHB=LGG (- 133 u, Figure 4.4d), 
oHB=FGG (- 147 u, Figure 4.4e), and oHB=YGG (-163 u, Figure 4.4f). Note, for CID of 
[oHB=GGG + H]+ (Figure 4.4a) the dominate m/z 237 ion can be both indicative the yǂ and [b2 
+ H2O]
+
 ions.  
CID of protonated oHB=AGG, oHB=VGG, oHB=FGG, and oHB=YGG also generated  
small (less than 10% relative intensity) fragment ions at m/z 162 and m/z 180, which appeared 
to be produced from losing 75 u (C-terminal Gly residue mass) and 57 u (Gly residue mass) 
respectively, presumably from m/z 237 (yǂ). Note, m/z 162 for [oHB=GGG + H]+ is the mass 
indicative of both the b1 ion and the loss of 75 u from m/z 237 (Figure 4.4a). Interestingly 
however, the m/z 180 peak proposed to be an apparent loss of 57 u from m/z 237 was also 
observed for [oHB=GGG + H]+ (Figure 4.4a), suggesting the m/z 237 peak observed for 
protonated oHB=GGG is a mixture of both the yǂ and [b2 + H2O]
+
 ions .   
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Figure 4.4 CID mass spectrum of protonated a) GGG, b) AGG, c) VGG, d) LGG, e) FGG, and f) 
YGG, imine-derivatized by condensation reaction with salicylaldehyde (oHB).  
  
  
  
  
  
  
  
a )   d )   
e )   
f )   
b )   
c )   
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CID of polar side-chain containing protonated oHB=SGG and oHB=TGG also generated 
the yǂ ion at m/z 237 (Figure 4.5a) and Figure 4.5b)), indicating the loss of 87 u (Ser) and 101 u 
(Thr) respectively. Interestingly, the product ion peak m/z 162 (i.e. the proposed C-terminal  
Gly loss from the yǂ ion) was observed at approximately 82% relative intensity for [oHB=TGG 
+ H]+ (Figure 4.5b), greater than that observed for the yǂ ion. More interestingly, however, the 
dominant fragment ion generated for CID of [oHB=TGG + H]+ was observed at m/z 294 (i.e., 
loss of 44 u) presumably indicative of eliminating the N-terminal amino acid side chain residue.   
 Pathways proposed for the loss of 44 u from protonated oHB=TGG are shown by Scheme 
4.1a, Scheme 4.1b, and Scheme 4.1c. Each path is initiated by protonation at the imine nitrogen 
followed by nucleophilic attack by the N-terminal amide oxygen on the benzyl carbon, 
generating an oxazole intermediate. Scheme 4.1a involves H-transfer from the Thr sidechain 
hydroxyl group to the N-terminal nitrogen and loss of acetaldehyde (44 u). In contrast, Scheme 
4.1b involves H-transfer from the Thr sidechain hydroxyl group to the second amino acid 
nitrogen, leading to loss of acetaldehyde. Scheme 4.1c involves H-transfer from the Thr 
sidechain methyl group to the second amino acid nitrogen, leading to the elimination of ethanol 
(44 u) to form the oxazole intermediate.   
Note, along Scheme 4.1b and Scheme 4.1c an m/z 162 fragment ion may be generated 
from the breakdown of the oxazole intermediate to eliminate GlyGly. Presumably, the 
unexpected large intensity observed for m/z 162 for CID of protonated oHB=TGG is 
representative of contributions from Scheme 4.1b, Scheme 4.1c and elimination of the C-
terminal glycine residue from the yǂ ion. CID of protonated oHB=SGG also generates a peak at 
m/z 294 (i.e., 30 u) with a relative intensity of approximately 4%. Lacking a methyl group at the 
N-terminal amino acid side-chain, the loss of 30 u from [oHB=SGG + H]+ is likely generated 
 87  
  
through a pathway similar to the oxazole mechanism proposed in Scheme 4.1a and Scheme 4.1b, 
assumedly to eliminate formaldehyde (30 u).   
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Figure 4.5 CID mass spectrum of protonated a) SGG and b) TGG, imine-derivatized by 
condensation reaction with salicylaldehyde (oHB)  
    
   
a) 
b) 
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Scheme 4.1 (a) Proposed sidechain hydroxyl → N-terminal nitrogen H-transfer fragmentation 
pathway for generation of m/z 294 by CID of protonated oHB=TGG. (b) Sidechain hydroxyl → 
amide nitrogen and (c) sidechain methyl → amide nitrogen H-transfer pathways for the generation 
of m/z 294, and secondary fragmentation pathway to generate m/z 162 for protonated oHB=TGG   
  
  
  
  
  
a )   
b )   
c )   
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4.2.3 CID-MSn investigations of novel yǂ generating fragmentation pathway  
Most interesting about the observed peak at m/z 237 generated from CID of protonated 
oHB=XGG tripeptides and m/z 497 generated from CID of [oHB=YGGFL + H]+ was the 
implication of a pathway that eliminates the N-terminal amino acid residue while conserving the 
derivatization. Specifically, not only may the N-terminal amino acid be directly determined from 
the apparent internal elimination pathway, but fragmentation (e.g., MS3) of the yǂ may also be 
protected from sequence scrambling effects if the conserved derivatization remains N-terminal 
to the remaining conserved primary sequence. Using protonated oHB=AGG as a model peptide 
ion, possible mechanisms to explain eliminating the residue mass of the N-terminal amino acid 
(i.e., 71 u for [oHB=AGG + H]+) are shown in Scheme 4.2a and Scheme 4.2b. In Scheme 4.2a, 
the reaction is initiated by proton mobilization to the second amino acid amide oxygen. The 
mobilization of the protonating proton is followed by nucleophilic attack of the imine nitrogen 
on the C-terminal amide carbon, forming a substituted ketopiperazine intermediate. The 
intermediate breaks down creating an imine product with a backbone hydroxyaziridine ring and 
neutral aziridinone loss, representing the elimination of 71 u.   
Scheme 4.2b, however, begins with protonation at the imine nitrogen atom, followed by 
nucleophilic attack by the second amino acid amide nitrogen on the N-terminal imine carbon, 
creating an imidazole-one intermediate. The formation of an imine-derivatized peptide that is 
one amino acid residue smaller with conserved primary sequence occurs via ring opening of the 
imidazole-one intermediate and consequential ejection of CO and an imine. Generation of an 
imidazole-one intermediate via amide nitrogen attack is similar to the mechanism proposed to 
explain H2O elimination from protonated tetraglycine.
27, 30, 168  
  
 
  
 
Scheme 4.2 Loss of N-terminal residue mass via a) ketopiperazine intermediate b) imidazole-one intermediate for model peptide ion 
[oHB=AGG + H]+. 
a )   
b )   
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Early evidence nucleophilic attack at the benzyl carbon, implicated in the yǂ ion Scheme 
4.2b, likely occurs for the oHB derivatized systems was a small fragment ion observed possibly 
indicative of eliminating the phenol moiety (i.e., 93 u + H) of each protonated oHB=XGG peptide 
evaluated by CID-MS2 (Figure 4.4). The proposed mechanism to lose 94 u is shown by Scheme 
4.3a and Scheme 4.3b. Scheme 4.3a involves protonation at the imine nitrogen, followed by 
nucleophilic attack by the amide nitrogen on the second amino acid residue on the benzyl carbon 
generating an imidazole-one intermediate. Hydrogen transfer from the N-terminal nitrogen to 
the oHB hydroxyl oxygen leads to breaking the benzyl carbon bond, eliminating water (18 u) 
and neutral benzyne (76 u). The resulting N-terminal imidazole-one ion represents a fragment 
ion identified by a total loss of 94 u.  
 
Scheme 4.3 Proposed mechanism for loss of 94 u from protonated oHB=XGG peptide species by 
(a) an imidazole-one intermediate pathway and (b) an oxazolidine-imine intermediate pathway  
a) 
b) 
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Scheme 4.3b begins with protonation at the imine nitrogen, followed however by 
nucleophilic attack by the N-terminal amide oxygen on the benzyl carbon to generate an oxazole 
intermediate. Resonance rearrangement to generate an oxazolidine-imine intermediate is 
followed by hydrogen transfer to the oHB hydroxyl oxygen analogous to Scheme 4.3a and 
resulting in the elimination of water and neutral benzyne. The resulting N-terminal oxazole-
imine ion also represents a fragment ion identified by a total loss of 94 u.   
To resolve the implicated loss of phenol moiety (i.e., 93 u + H), the CID spectrum of the 
protonated unmodified GGA (Figure 4.6a) and GGA imine-derivatized by reaction with 
benzaldehyde (Bz) and oHB were obtained (Figure 4.6b and Figure 4.6c), respectively). By 
Scheme 4.3a and Scheme 4.3b, the loss of 94 u from oHB derivatized protonated peptides was 
presumed to involve hydrogen transfer from the protonated imine-nitrogen to the N-terminal 
hydroxybenzyl OH. It was hypothesized therefore the loss of 94 u would not be observed for 
CID of protonated peptides imine derivatized by reaction with benzaldehyde due to the lack of 
an OH substituent.   
The CID-MS2 spectrum of protonated unmodified GGA generated the fragment ions 
identified by loss of 18 u (m/z 186) and 45 u (m/z 159), as well as a dominant b2 ion at m/z  
115 (Figure 4.6a). The y1 and a2 ions were also observed for [GGA + H]
+. CID of [Bz=GGA + 
H]+ generated a fragmentation pattern with a wider array of sequence ions (Figure 4.6b), 
consistent with that observed for N-terminal imine-derivatization by oHB. The dominant 
fragment ion was observed as the b2 ion (m/z 203). The b1 and y2 ions were observed at small 
relative intensities, and the a2 ion at approximately 12% relative intensity. Interestingly, the y
ǂ 
ion (m/z 235) generated from [Bz=GGA + H]+ identified by loss of 57 u (i.e., Gly) was observed 
at approximately 22% relative intensity inconsistent with the dominant yǂ ion observed for the 
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XGG imine-derivatized peptide species. In contrast, the yǂ ion (m/z 251) generated from CID of 
[oHB=GGA + H]+ (Figure 4.6c), was observed at approximately 76% relative intensity, 
suggesting an imine-modifier/structural effect on the rate of the reaction mechanism generating 
the yǂ ion. CID of [oHB=GGA + H]+ also generated the full series of b and a ions, as well as the 
y2 ion at m/z 147 (Figure 4.6c)). The dominant ion was observed as the b2 ion at m/z 219. 
Consistent with the CID-MS2 spectra of the protonated oHB=XGG peptides, the loss of 18 u is 
observed, as well as the [b1 + H2O]
+ ion at m/z 180 and the [b2 + H2O]
+ ion at m/z 237.    
Expectedly, the loss of 94 u presumed indicative of losing water and neutral benzyne was 
observed for [oHB=GGA + H]+ at m/z 214, however not observed for [Bz=GGA + H]+ to 
generate m/z 198 (Figure 4.6b). It was assumed, therefore, the 94 u loss from [oHB=GGA + H]+ 
likely originates from the N-terminus as postulated by Scheme 4.3. The apparent benzyne loss 
for [oHB=GGA + H]+ also seemed to further implicate the benzyl carbon as a possible 
electrophilic site as implicated by the proposed imidazole-one pathway for generating the yǂ ion. 
Additionally, no peak at m/z 215 was observed to indicate a comparable benzyne loss from 
[Bz=GGA + H]+  by some unknown mechanism.  
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Figure 4.6 CID mass spectrum of protonated a) GGA, and GGA imine-derivatized by 
condensation reaction with b) benzaldehyde (Bz) and c) salicylaldehyde (oHB).  
a) 
b) 
c) 
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4.2.3.1 yǂ generation from unprotonated imine-derivatized PGG  
To investigate the viability of the imidazole-one mechanism (Scheme 4.2b) as the likely 
pathway for yǂ ion generation, the CID spectra of underivatized protonated PGG (Figure 4.7a) 
and oHB derivatized PGG (Figure 4.7b) were obtained. Reactions of aromatic aldehydes and 
proline have been studied by experimenters and determined to generate a benzyl iminium 
zwitterion species in equilibrium with a benzylamine oxazolidinone isomer.169 It was reported, 
the benzylamine oxazolidinone species is likely generated by nucleophilic attack by the carboxy 
oxide ion on the benzyl carbon, converting the imine nitrogen to an amine.169 Interestingly, the 
reported benzylamine oxazolidinone structure is similar to the imidazole-4one intermediate 
formed by amide nitrogen attack proposed for eliminating the N -terminal amino acid residue to 
create the yǂ ion. Additionally, imine derivatization of PGG by condensation reaction with 
salicylaldehyde was thought to generate an oHB=PGG iminium ion similar in structure of the 
benzyl iminium species reported for proline and aromatic aldehyde reactions.169 Specifically, the 
structure of [oHB=PGG]+ was presumed to be charged at the N-terminal imine nitrogen similarly 
to the starting structure proposed in the imidazole-one mechanism (Scheme 4.2b), however, 
absent a conventional mobile proton (Figure 4.8a).  
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Figure 4.7 The CID-MS2 spectrum of a) protonated PGG, and PGG derivatized with b) 
salicylaldehyde (oHB) and c) benzaldehyde (Bz)   
a) 
b) 
c) 
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a)    
  
  
 
Figure 4.8 Proposed structure of non-protonated a) PGG and protonated b) AGG imine 
derivatized by condensation reaction with salicylaldehyde (oHB).  
  
The fragmentation pattern of protonated underivatized PGG generated a dominant b2 ion 
peak, followed by the a1 peak at approximately 30% relative intensity thought to be generated 
through the a1-yz pathway (Scheme 1.3).
170 The a2 and y2 product ions were also observed at 
relative intensities less than 4%. Interestingly, in contrast to the protonated imine-derivatized 
XGG peptides, the CID-MS2 spectrum of unprotonated [oHB=PGG]+ (Figure 4.7b) generated a 
smaller number of sequence ions than underivatized PGG. Additionally, the dominant product 
ion observed for CID of [oHB=PGG]+ was the b1 ion, while the b2 and a1 ions were observed at 
a relative intensity less than 2%. Presumably, the simple fragmentation pattern of [oHB=PGG]+ 
is indicative of having a “fixed” N-terminal charge at the imine nitrogen (Figure 4.8a) in lieu of 
the added/protonating proton whose mobilization is classically used to describe peptide 
fragmentation and the generation of sequence ions.26 Formation of sequence ions from  
b )   
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CID of unprotonated [oHB=PGG]+ was therefore thought to be governed by intramolecular 
hydrogen transfer reactions involving the oHB hydroxy hydrogen, as proposed in Scheme 4.4a 
and Scheme 4.4b.  
 
Scheme 4.4 Proposed intramolecular hydrogen transfer a) b1 → a1 pathway, and b) b2 – y1 pathway 
for [oHB=PGG]+.  
   
a) b) 
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More interestingly, CID of [oHB=PGG]+ generated the yǂ ion indicative of losing the 
residue mass of proline (- 97 u) at m/z 237. For completeness, an adapted ketopiperazine 
(Scheme 4.5a) pathway was postulated for the loss of 97 u from [oHB=PGG]+. The mechanism 
involves H-transfer from the oHB hydroxyl substituent to the amide oxygen of the second amino 
acid residue. Nucleophilic attack by the proline nitrogen on the carbonyl carbon forms a (PGG)-
ketopiperazine intermediate. The collapse of the intermediate results in an opening of the proline 
ring and formation of a 3-[3-(aziridin-1-yl)propyl]aziridin-2-one intermediate. Break down of 
the aziridine-2-one moiety ejects CO. The formed butyl imine cyclizes creating a proton shared 
1-pyrroline/hydroxyaziridine dimer. Dissociation of the dimer leads to either a protonated 
pyrroline ion or protonated hydroxyaziridine ion indicative of a 97 u loss. In contrast, the adapted 
(PGG)-imidazole-one pathway shown by Scheme 4.5b for loss of 97 u does not require opening 
the proline ring, but instead involves elimination of an intact proline ring in a mechanism 
identical stepwise to that proposed for the loss of 71 u from protonated oHB=AGG (Scheme 
4.2b).   
To better resolve the mechanism for elimination 97 u from imine derivatized PGG, imine 
derivatization by condensation reaction with benzaldehyde (Bz) was obtained (Figure 4.7c) 
given Scheme 4.5a relies on intramolecular H transfer from the hydroxybenzyl OH group to a 
carbonyl oxygen. Interestingly, the b1 ion dominant for CID of [oHB=PGG]
+ was not generated 
for [Bz=PGG]+, nor the a1 ion. Additionally, the a2 ion is produced as a small ion peak (< 2% 
ion intensity) and the b2 ion at approximately 10% intensity for CID of [Bz=PGG]
+. Assumedly, 
the small sequence ion peak intensities are a consequence of benzaldehyde lacking the hydroxy 
substituent proposed to participate in intramolecular H-transfer reactions.    
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Scheme 4.5 The a) ketopiperazine and b) imidazole-one pathway (boxed) adapted for the loss of 
97 u via CID of [oHB=PGG]+  
a )   
b )   
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More interestingly, the ion peak representative of losing 97 u (yǂ) at m/z 221was observed 
as the dominant peak for CID of [Bz=PGG]+ (Figure 4.7c) despite lacking the hydroxy 
substituent implicated in Scheme 4.5a. The observance of the yǂ peak for imine-derivatized 
oHB=PGG and Bz=PGG both presumed to have a fixed N-terminal charge, suggested the 
imidazole-one pathway (Scheme 4.2b and Scheme 4.5b) are the likely mechanisms for 
eliminating the residue mass of the N-terminal amino acid. Additionally, H-transfer from the 
protonated nitrogen of the proposed (PGG)-imidazole-one intermediate in Scheme 4.5b to the 
C-terminal amide nitrogen followed by elimination of the C-terminal Gly implicates a possible 
pathway for generating the observed b2 and a2 ions from [Bz=PGG]
+.  
  
4.2.3.2 CID-MS3 determination of yǂ ion identity   
Under low energy CID, the fragmentation pattern and relative intensities of observed 
product ions depend upon the internal energy and structure of the precursor ion under analysis.171 
However, ion structure cannot be implicitly determined from mass spectra. Nevertheless, the 
uniqueness of the fragmentation pattern obtained from the CID of precursor and product ions is 
the basis of tandem mass spectrometric techniques for peptide identification. More importantly, 
an ion with a particular structure and composition under comparable conditions will generate the 
same fragmentation pattern each time. Note the imidazole-one pathway for the loss of 71 u (i.e., 
the residue mass of Ala) from the model imine peptide ion [oHB=AGG + H]+ (Scheme 4.2b) 
generates a final product ion [oHB=GG + H]+ with a structure identical to GlyGly independently 
derivatized with oHB. Presumably therefore, if the structure of the product ion generated from 
the loss of 71 u from [oHB=AGG  
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+ H]+ is identical to the structure of protonated GlyGly independently derivatized with oHB the 
CID mass spectrum of both ions will be indistinguishable from each other, further implicating 
the imidazole-one mechanism and N-terminal amino acid elimination.  
To help resolve the structure of and mechanism for generating the yǂ ion, the CID mass 
spectra of protonated tetrapeptide AGGG and protonated tripeptide GGG both imine-derivatized 
with 2-hydroxybenzaldehyde (oHB) were obtained. Note, the proposed structure of a yǂ product 
ion generated via the proposed imidazole-one mechanism (Scheme 4.2b)) for protonated 
oHB=AGGG would be the structure of the protonated tripeptide GGG imine-derivatized with 
oHB. The mass spectrum of a yǂ ion generated from CID of [oHB=AGGG + H]+ was therefore 
expected to be indistinguishable from the CID mass spectrum of [oHB=GGG + H]+, assuming 
the loss of 71 u is observed and the imidazole-one pathway is the responsible mechanism for the 
elimination.  
Figure 4.9a shows the CID-MS2 spectrum for [oHB=AGGG + H]+. Consistent with the 
fragmentation pattern observed for imine modified tripeptides (Section 4.2.2), the fragmentation 
pattern of the imine-modified tetrapeptide [oHB=AGGG + H]+ is abundant in a- and b-type 
fragment ions. The most abundant product ion peak generated from CID of [oHB=AGGG +H]+ 
(Figure 4.9a) was the b2
+ ion at m/z 233. The b1, b3, a1, a2, and a3 ions are also observed for CID 
of [oHB=AGGG + H]+, indicating the generation of the complete series of a and b ions. The [b1 
+ H2O]
+ (at m/z 194), [b3 + H2O]
+ (at m/z 308), y2 and y3 ions are also observed. As seen for the 
oHB derivatized tripeptides studied (Chapter 4.2.3), the loss of 94 u, presumed to be the loss of 
benzyne and water, was also detected at m/z 271 with an ion intensity less than 1% (Figure 4.9a). 
The water loss product ion is also observed at m/z 347.  
   
 104  
  
   
   
   
  
 
Figure 4.9 a) CID-MS2 spectrum of protonated AGGG imine-derivatized with salicylaldehyde 
(oHB), [oHB=AGGG + H]+, b) CID-MS3 spectrum of product ion m/z 294 generated from the 
loss of 71 u from [oHB=AGGG + H]+, c) CID-MS2 spectrum of protonated GGG  imine-
derivatized with salicylaldehyde, [oHB=GGG + H]+.  
a) 
b) 
c) 
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 CID of [oHB=AGGG + H]+ also generated a loss of 71 u, consistent with the residue mass 
of the N-terminal amino acid (alanine), to produce the m/z 294 fragment ion (yǂ) with an intensity 
of approximately 85%. Interestingly, a small peak with an ion intensity less than 1% at m/z 237 
(Figure 4.9a) is also observed that appears to be the loss of 57 u consistent with losing the residue 
mass of glycine from the m/z 294 ion. More interestingly, the CID-MS3 spectrum of the yǂ ion 
isolated from CID of [oHB=AGGG + H]+ (Figure 4.9b) shows m/z 237 as the dominant fragment 
ion peak, consequently indicating the origin of the small m/z 237 peak observed from CID-MS2 
of [oHB=AGGG + H]+ (Figure 4.9a) is likely from dissociation of the yǂ ion (m/z 294).   
Both the ketopiperazine pathway (Scheme 4.2a) resulting in an imine-modified N-terminal 
aziridine product ion structure and the imidazole-one pathway (Scheme 4.2b) resulting in an N-
terminal imine-modified peptide product ion structure were applied as possible mechanisms for 
the loss of 71 u from [oHB=AGGG + H]+ generating m/z 294. Consequently, two pathways were 
postulated for generating the loss of 57 u from m/z 294 starting from the aziridine (Scheme 4.6a) 
and primary peptide (Scheme 4.6b) product ion structures.   
  
 106  
  
 
  
 
Scheme 4.6 a) Proposed mechanism for the elimination of 57 u from the imine-modified aziridine 
peptide structure of product ion m/z 294 generated from CID of [oHB=AGGG + H]+, b) proposed 
mechanism for the elimination of 57 u from the imine-modified primary peptide structure of 
product ion m/z 294 generated from CID of [oHB=AGGG + H]+  
  
  
 
a )   b )   
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Scheme 4.6a for the loss of 57 u from m/z 294 involves an opening of the aziridine ring 
generating an imine-modified primary GGG structure, protonated at the N-terminal carbonyl 
oxygen. Nucleophilic attack of the N-terminal carbonyl carbon by the C-terminal nitrogen 
generates an imidazole-one intermediate. The collapse of the imidazole ring generates the loss 
of 57 u by eliminating CO and HN=CH2. Scheme 4.6b for the loss of 57 u from product ion m/z 
294 with an imine-modified GGG structure was adapted from the imidazole-one pathway 
described by Scheme 4.2b, implicating the elimination of the product ions N-terminal amino 
acid residue. Given the fragmentation of both initial product ion structures can generate a loss of 
57 u, the observance of the m/z 237 peak in the CID mass spectrum of m/z 294 could not be used 
to resolve the structure of m/z 294 implicitly.  
Interestingly however, the CID-MS2 fragmentation pattern of [oHB=GGG + H]+ (Figure 
4.9c), independently modified, was indistinguishable from the CID spectrum of the m/z 294, 
suggesting the identity/structure of m/z 294 (yǂ ion) is identical to [oHB=GGG + H]+. 
Additionally, the identical spectra further implicate the imidazole-one pathway as the 
mechanism for the loss of 71 u from [oHB=AGGG + H]+ representative of eliminating the N-
terminal amino acid residue. Furthermore, the loss of 57 u observed from CID of the yǂ ion 
generated from CID of [oHB=AGGG + H]+ was implicated as the loss of the new N-terminal 
amino acid residue (i.e., glycine), suggesting the derivatization and the N-terminal elimination 
mechanism is conserved through multiple stages of MSn. Consequently, new nomenclature (e.g., 
bi
ǂ, yi
ǂ, and ai
ǂ) (Figure 4.10) was adopted to distinguish the sequence ions originating from the 
CID of the yǂ ion:  
i = 1, 2, 3, … (R – n + 1), where R is the number of amino acid residues in the peptide 
sequence and n the number of MS stages. The “ǂ” is used to indicate its origin from CID of a yǂ 
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ion. Additionally, the loss of the apparent N-terminal amino acid (glycine) from the yǂ ion (m/z 
294) is represented by y(2)ǂ to indicate the loss of the second N-terminal amino acid in the 
sequence.  
 
  
 
Figure 4.10 Nomenclature for sequence ions generated from CID of yǂ ions. 
 109  
  
4.2.4 IRMPD spectroscopy determination of the product ion generated by 
the loss of 71 u from protonated oHB=AGG.  
To more clearly resolve the pathway for eliminating the apparent N-terminal amino acid 
residue from imine-modified peptides, IRMPD spectroscopy was used to determine the structure 
of the precursor and product ions using [oHB=AGG + H]+ as the model. Determining the 
structure of the precursor ion before elimination of 71 u and after the elimination of 71 u will 
give a more unambiguous indication of the elimination mechanism as if to model the beginning 
and end of the reaction pathway. The proposed ketopiperazine (Scheme 4.2a) and imidazole-one 
(Scheme 4.2b) pathways for eliminating the N-terminal amino acid residue were used as the 
starting point of this study, beginning with the site of protonation.  
 For intact, protonated oHB=AGG, several minima were identified by DFT calculations, 
including structures in which the imine nitrogen atom is protonated (Scheme 4.2b) and those for 
which the amide oxygen served as the protonation site (Scheme 4.2a). The four lowest energy 
structures are shown in Figure 4.11 and the relative energies provided in Table 4.1. The lowest 
energy structure determined for protonated oHB=AGG was structure M1 (Figure 4.11a), 
featuring a β-strand cationized with the proton positioned at the imine nitrogen atom. In order of 
increasing energy, structure M2 is also protonated at the imine nitrogen atom, though differed 
in the angle of a dihedral angle allowing H-bonding interaction between the imine and the C-
terminal oxygen atom. Structures M3 and M4 were protonated at the amide oxygen exhibiting 
energies 9.5-16.2 kcal/mol higher than M1. The experimentally determined IRMPD spectrum of 
protonated oHB=AGG (Figure 4.12a) was compared to those predicted by DFT for the lowest 
energy nitrogen-protonated and oxygen-protonated species M1 (Figure 4.12b) and M3 (Figure 
4.12c)), respectively. The best agreement to the experimental IRMPD spectrum was observed 
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for the theoretical spectrum of structure M1, strongly suggesting the imine nitrogen as the 
intrinsic protonation site for protonated oHB=AGG.    
 
  
  
 
Figure 4.11 Lowest energy structures predicted by DFT for protonated oHB=AGG. Nitrogen 
(blue), oxygen (red), carbon (dark grey), hydrogen (light grey).  
 
Table 4.1. Electronic, zero-point, and relative energies of minima determined for oHB=AGG  
(M1→4) and possible products created by N-terminal amino acid residue elimination (M1→10).  
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Figure 4.12. a) IRMPD spectrum of protonated oHB=AGG compared to the predicted spectra of 
lowest energy, b) imine-N protonated (structure 1), and c) amide-O protonated (structure 2) 
protonated oHB=AGG. The experimental IRMPD spectrum from (a) is transposed as a light grey 
trace in (b) and (c) for comparison.  
a) 
b) 
c) 
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Using the product ion structures proposed as a result of the ketopiperazine pathway 
(Scheme 4.2a) and the imidazole-one pathway (Scheme 4.2b) possible structures (Figure 4.13) 
resulting from the elimination of 71 u were identified using DFT (relative energies provided in 
Table 4.1). The identified structures M5, M6, and M7, represent product ion structures 
representative of the ketopiperazine pathway. Structures M5 and M7 both feature an intact 
hydroxyazridine ring, while structure M6 is resultant of the aziridine ring opening to form an 
oxygen-protonated oHB=GG structure in a cis conformation.   
However, the three low energy structures, identified as 10.8-56.4 kcal/mol lower in energy 
than those implicated in the ketopiperazine mechanism, belonged to structures M8, M9, and 
M10. These structures (M8-M10) are all conformational isomers of oHB=GG, possibly 
generated through the imidazole-one mechanism. The lowest energy structure, M8, determined 
by DFT, corresponds to a β-strand, imine nitrogen protonated structure. It is important to note 
the main difference between the structures M8 and M9 separated by 2.4 kcal/mol in energy, is 
the change in the dihedral angle of product ion structure M9, breaking of the intramolecular 
hydrogen bond between the protonated imine nitrogen and the orthopositioned hydroxy 
substituent of the imine modifier. These structures implicated the possible importance of an 
intramolecular hydrogen bonding effect (shown by structure M8) for promoting the presumed 
N-terminal amino acid residue loss.   
Figure 4.14a shows the IRMPD spectrum obtained from the m/z 237 product ion created 
by eliminating 71 u from [oHB=AGG + H]+. The theoretical IRMPD spectra obtained of the 
hydroxyazridine product ion structure, M5 (Figure 4.14c), as well as the trans amide oHB=GG 
structure, M8 (Figure 4.14b), was compared to the experimental IRMPD spectrum of product 
ion m/z 237 in Figure 4.14a. Additionally, the experimental IRMPD spectrum was obtained of 
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protonated dipeptide GG (Figure 4.14d), independently imine derivatized by condensation 
reaction with oHB, and compared to the m/z 237 spectrum shown in Figure 4.14a). The best 
agreement to the IRMPD spectrum of m/z 237 was observed from the theoretical spectrum of 
structure M8 (Figure 4.14b), as well as the experimental spectrum of [oHB=GG + H] derivatized 
independently (Figure 4.14d). Near identical agreement between the m/z 237 IRMPD spectrum 
and that of [oHB=GG + H]+ strongly implicated the m/z 237 ion identity as oHB=GG. 
Agreement between the theoretical spectrum of structure M8 indicative of oHB derivatized GG 
protonated at the imine nitrogen, further strengthened the evidence supporting the 71 u loss 
generated from CID of [oHB=AGG + H]+ is indicative of eliminating the N-terminal residue 
mass of alanine from the protonated imine-derivatized peptide. Additionally, it strongly 
identified the proposed imidazole-one mechanism (Scheme 4.2b) as the pathway leading to the 
N-terminal residue loss and generation of the yǂ ion.  
 
 
Figure 4.13 Possible structures of product ions generated by the elimination of 71 u (N-terminal 
amino acid residue) from activation of [oHB=AGG + H]+.   
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Figure 4.14. a) IRMPD spectrum of product ion m/z 237 generated by the loss of 71 u from 
protonated oHB=AGG compared to the predicted spectra of the lowest energy structures formed 
by the b) imidazole-one pathway (structure M8) and c) the ketopiperazine pathway (structure M5). 
d) IRMPD spectrum of protonated oHB=GG. The experimental IRMPD spectrum from (a) is 
transposed as a light grey trace in (b), (c), and (d) for comparison.  
a) 
b) 
c) 
d) 
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4.3 Conclusions  
In the presented study, when compared to the CID mass spectrum of protonated 
unmodified Leu-enkephalin (YGGFL), the CID mass spectrum of protonated YGGFL imine-
modified by condensation reaction with salicylaldehyde (oHB) generated a fragmentation 
pattern with a more extensive array of a and b type sequence ions. Specifically, the full series of 
b ions (b4 to b1) were observed, as well as ions a4, a2, and a1. “Scrambled” product ions generated 
from CID of unmodified [YGGFL + H]+ previously observed and determined by the work of 
Vachet and coworkers,31 were not observed in the CID-MS2 spectrum of [oHB=YGGFL + H]+ 
implicating N-terminal imine modification was successful at eliminating sequence scrambling.  
More interestingly, CID of [oHB=YGGFL + H]+ produced a novel product ion (yǂ ion) at 
m/z 497 indicative of eliminating the residue mass of the N-terminal amino acid, thus a method 
to directly identify the N-terminal amino acid. The CID mass spectra of oHB derivatized 
tripeptides GGG, AGG, VGG, LGG, FGG, YGG, SGG, and TGG also generated the yǂ ion 
indicative of losing the residue mass of each respective N-terminal amino acid. Additionally, the 
series of imine-modified tripeptides provided a representation of the general fragmentation 
pattern generated from N-terminal imine-derivatization. In comparison to the underivatized 
analogs, the imine-modified peptides produced a more extensive/complete series of N-terminal 
a and b type product ions to be used for enhanced peptide sequencing, so named using the 
traditional nomenclature despite the presence of the modification. The generation and ion 
intensity of y-type product ion series appeared to be reduced, however, presumably due to the 
N-terminal imine nitrogen retaining the protonating proton following the cleavage step of the 
b/y pathway.   
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The pathway resulting in the apparent elimination of the residue mass of the N-terminal 
amino acid was investigated further using the model imine-derivatized peptide oHB=AGG by 
IRMPD spectroscopy and density functional theory (DFT).  Possible DFT predicted structures 
for the [oHB=AGG+H]+ precursor ion and the m/z 237 product ion resulting from loss of 71 u 
were identified and the corresponding theoretical IRMPD spectra compared to those determined 
experimentally. The IRMPD spectrum of the [oHB=AGG+H]+ precursor ion matched that 
predicted for a β-strand, imine nitrogen protonated conformer, while the m/z 237 product ion 
spectrum matched that predicted for a β-strand, imine nitrogen protonated oHBGG conformer.   
Additionally, the IRMPD spectrum of [oHB=GG + H]+ derivatized independently from 
the dipeptide GG, matched near identically that of the m/z 237 product ion. It was concluded, 
therefore, the apparent N-terminal amino acid residue mass is eliminated through a pathway that 
involves a nucleophilic attack by the amide nitrogen of the second amino acid residue in 
sequence on the benzyl carbon N-terminal to the protonated imine nitrogen generating an 
imidazole-4-one intermediate. The collapse of the imidazole ring generates the β-strand, imine 
nitrogen protonated oHB=GG conformer with a retained primary sequence.   
The confirmed DFT predicted β-strand structures of the precursor ion [oHB=AGG + H]+ 
and N-terminal amino acid elimination product ion [oHB=GG + H]+ protonated at the N-terminal 
imine revealed a possible hydrogen bonding interaction between the N-terminal imine and the 
hydroxybenzyl oxygen. Interestingly, comparison of the mass spectra of protonated Bz=GGA 
and oHB=GGA suggested N-terminal amino acid elimination becomes less competitive when 
the hydrogen bonding interaction between the protonating proton and the hydroxybenzyl oxygen 
at the ortho position of the modifier is interrupted/missing. An investigation was performed into 
the apparent influence the derivatizing aldehyde has on the novel fragmentation pathway 
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eliminating the N-terminal amino acid. Particularly considering modifications that eliminate the 
apparent hydrogen bonding interaction at the protonated N-terminus, can reveal the influence 
imine modifier structure has on product ion formation from imine derivatized peptides. These 
studies are presented in Chapter 5.      
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CHAPTER 5  
PRODUCT ION DISTRIBUTIONS FROM CID OF MODEL 
PROTONATED PEPTIDE, ALANYLGLYCYLGLYCINE, 
IMINE-DERIVATIZED BY DIFFERENT N-TERMINAL 
MODIFIERS   
5.1 Introduction  
Notable influences on CID generated product ion distributions for protonated peptide ions 
include charge state, the composition of basic amino acid residues, and the identity of the amino 
acid adjacent to the cleaved bond.172-177 For example, the presence of proline in peptide sequence 
results in fragment ion peaks consistent with bond cleavage N-terminal to the proline residue, 
known as the proline effect.26, 178, 179 However, inadequacy of current peptide sequencing 
methods is the disregard of observed product ion intensities while focusing wholly on m/z data, 
or only pragmatically incorporating ion intensity information by indirect application of the most 
abundant peaks.180 However, the current treatment of ion intensity data is a consequence of the 
inability to accurately and explicitly predict product ions and their abundance.181, 182   
Some work has gone forth to computationally simulate and predict peptide MS/MS spectra 
intensity patterns derived from low-energy CID by incorporating known, and author observed 
CID spectra within database searches.181, 182 Database methods that combine peak intensity 
information with amino acid composition have also been shown to improved rates of peptide 
identification.183, 184 Yet, these methods presumably would fall short in their predictions of novel 
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peptides and modifications with unknown and lesser studied/documented fragmentation 
patterns.   
In the present case, IRMPD spectroscopy of model [oHB=AGG + H]+ has indicated the 
imidazole-one pathway (Scheme 4.2b) as the likely charge-mediated mechanism for generating 
the novel yǂ ion indicative of eliminating the N-terminal amino acid residue. Specifically, 
IRMPD spectroscopy has indicated the ionizing proton of [oHB=AGG + H]+ is located at the N-
terminal imine nitrogen, coinciding with the first step of the imidazole-one pathway (Chapter 
4).185 Additionally, structural modeling of [oHB=AGG + H]+ revealed a possible stabilizing 
hydrogen-bonding interaction between the hydroxybenzyl oxygen atom and the protonating H+ 
(Figure 4.11). Assumedly, the apparent H-bonding interaction promotes protonation at the imine 
nitrogen, and therefore, the charge mediated N-terminal amino acid loss.  
To investigate the apparent hydrogen bonding interaction as a feature influencing yǂ ion 
peak intensity and to observe the general product ion distribution of imine-derivatized peptides, 
the imine modifier was systematically exchanged for the model peptide AGG and the CID-MS2 
spectrum obtained. Benzaldehyde, x-methoxybenzaldehyde, and x-hydroxybenzaldehyde 
(where x = ortho, para, or meta) were used to generate imine derivatized AGG peptides with the 
hydrogen-bonding substituent (i.e., OH and -OMe) missing or positioned further away from the 
DFT determined imine nitrogen protonation site. It was hypothesized imine modifications 
lacking the H-bonding interaction generate the yǂ ion at a lesser ion intensity than observed for 
[oHB=AGG + H]+ (i.e., 100%).  
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5.2 Results and Discussion  
5.2.1 CID-MS2 spectra of protonated benzyl-, hydroxybenzyl-, and 
methoxybenzyl- imine modified AGG  
Figure 5.1a and Figure 5.2a show the CID-MS2 spectra of protonated benzyl imine (Bz) 
derivatized AGG, and the CID-MS2 spectra of para (p), meta (m), and ortho (o) hydroxybenzyl 
imine (HB) derivatized AGG are shown in Figure 5.1b, Figure 5.1c, and Figure 5.1d, 
respectively. Figure 5.2b, Figure 5.2c, and Figure 5.2d show the CID-MS2 mass spectra for the 
para (p), meta (m), and ortho (o) methoxybenzyl imine (MB) derivatized AGG peptides, 
respectively. For convenience, the structure and observed sequence ions are listed in Table 5.1.  
The CID-MS2 spectra of protonated oHB=AGG, oMB=AGG, mHB=AGG, mMB=AGG,  
pHB=AGG, and pMB=AGG all generated the complete series of bx and ax ions. However, the 
b1 ion was observed at a relative intensity less than 2% for protonated oMB=AGG, mHB=AGG, 
mMB=AGG, pHB=AGG, and pMB=AGG. The y2 ion was not observed in the CID-MS
2 spectra 
of the investigated imine-derivatized AGG species except for oHB=AGG at a relative intensity 
less than 1%. Water loss is also observed for each imine-derivatized AGG species. The 
[b2+H2O]
+ and [b1+H2O]
+ ions were observed for protonated oHB=AGG, oMB=AGG, 
mHB=AGG, mMB=AGG, and pMB=AGG at relative intensities less than 2%. The [b2+H2O]
+ 
ion is also observed for protonated pHB=AGG.  
  
 
Figure 5.1 CID-MS2 spectrum of protonated a) Benzaldehyde AGG, b) p-Hydroxybenzaldehyde AGG, c) m-Hydroxybenzaldehyde  
AGG, d) o-Hydroxybenzaldehyde AGG.    
   
      
   a) b) 
c) d)
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Figure 5.2 CID-MS2 spectrum of protonated a) Benzaldehyde AGG, b) p-Methoxybenzaldehyde AGG, c) m-Methoxybenzaldehyde  
AGG, d) o-Methoxybenzaldehyde AGG.    
    
      
a) b) 
c) d) 
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Table 5.1. Structure of protonated benzyl, hydroxybenzyl, and methoxybenzyl imine-derivatized 
AGG and list of CID generated sequence ions.   
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Interestingly, a product ion is observed at m/z 122 for CID of protonated pHB=AGG 
(Figure 5.1b) and mHB=AGG (Figure 5.1c), with a relative intensity less than 2% that appears 
to be an N-terminal immonium ion (NIm
+) containing the derivatization and the N-terminal 
nitrogen. A comparable product ion is observed at m/z 136 from CID of protonated pMB=AGG 
(Figure 5.2b), mMB=AGG (Figure 5.2c), and oMB=AGG (Figure 5.2d). Scheme 5.1 shows a 
possible mechanism for generating the proposed NIm
+ ion that includes N-terminal nitrogen 
protonation followed by nucleophilic attack of the neighboring amide nitrogen on the N-terminal 
side alpha carbon to produce an aziridine-immonium proton shared dimer. Dissociation of the 
dimer then leads to either generation of the NIm
+ ion with an m/z of 122 or 136 for protonated 
HB derivatized and MB derivatized AGG, respectively, or an aziridine ion that collapses to form 
a C-terminal containing imine ion with an m/z of 159 - observed at a low relative intensity for 
protonated Bz=AGG (Figure 5.1a) and mHB=AGG (Figure 5.2c).  
Interestingly, the yǂ ion corresponding to the elimination of the N-terminal amino acid was 
observed as the most abundant product ion for each protonated AGG peptide derivatized with 
hydroxybenzaldehyde and methoxybenzaldehyde despite the benzyl substituent position. An ion 
intensity of 90.48% was observed for protonated Bz=AGG. However, the ion intensity of 
product ions generated from the different hydroxybenzyl and methoxybenzyl peptide-imine 
isomers were observed to vary, indicating an apparent effect the modifier structure has on the 
peptide ion dissociation chemistry.   
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Scheme 5.1 Proposed mechanism for the formation of the proposed N-terminal immonium ion 
generated from protonated AGG imine derivatized by reaction with salicylaldehyde.   
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5.2.2 Energy (NCE) and activation time (t) resolved dissociation profiles  
Energy-resolved collision-induced dissociation tandem mass spectrometry, performed by 
collecting ion intensity data over a stepwise increase of collision energy to obtain a dissociation 
curve (profile), has been used to investigate the structures of gas-phase ions.186-192 These 
experiments exploit the effect the internal energy distribution of excited ions, the dynamics of 
activation and the activation time scale have on product ion formation and intensity.193 
Particularly, differences in the position and shape of obtained dissociation curves have been 
reported as evidence of isomeric differentiation/identification (e.g., subtle differences in 
structure)194, 195 and qualitative analysis of the energy required to dissociate the precursor ion of 
study.193-202  
To elucidate the effect of N-terminal modifier structure on the fragmentation of imine-
derivatized peptides, energy-resolved dissociation profiles of protonated benzyl-, 
hydroxybenzyl-, and methoxybenzyl- imine derivatized AGG were obtained. These dissociation 
curves (profiles) were generated by plotting fragmentation yield (FY) as a function of collision 
energy.194, 195, 196, 199, 203 Equation 5.1 (where Itotal is the total sum of product ion intensities and 
Iprecursor the precursor ion intensity) depicts when FY = 0 the precursor ion is unfragmented, and 
completely dissociated at FY = 1. A sigmoidal fit was determined for each profile curve with an 
R2 value ≥ 0.98 and a 99% confidence interval.194, 195    
  
Equation 5.1 𝐹𝑟𝑎𝑔𝑚𝑒𝑛𝑡𝑎𝑡𝑖𝑜𝑛 𝑌𝑖𝑒𝑙𝑑 =  
𝐼𝑡𝑜𝑡𝑎𝑙 − 𝐼𝑝𝑟𝑒𝑐𝑢𝑟𝑠𝑜𝑟
𝐼𝑡𝑜𝑡𝑎𝑙
 =  
∑𝑝𝑟𝑜𝑑𝑢𝑐𝑡 𝑖𝑜𝑛 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑖𝑒𝑠
𝐼𝑡𝑜𝑡𝑎𝑙
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Semi-quantitative approaches for profile curve analysis include: determining the collision 
energy required to bring about a certain percentage of fragmentation yield or product ion 
intensity (i.e. 5% (E5%), 10% (E10%), or 50% (E50%)),
192, 196, 198, 203 and linear extrapolation194, 197, 
199, 200 of the profile curve slope through E50% to the baseline (x-axis) resulting in an appearance 
(threshold) energy for the onset of precursor ion dissociation. The values resulting from each 
approach have been used to qualitatively address the stability of precursor ions affected by 
changes in precursor ion structure.194, 196-199 Both linear extrapolation and E50% determination of 
the fitted sigmoidal curve were utilized here for CID of each investigated imine derivatized AGG 
analog.  
It is important to note, consistent with common observations for the fragmentation of large 
precursor ions,204 the appearance energies (AE) and E50% values of each imine-derivatized profile 
curve (Figure 5.3 and Figure 5.4) was observed to occur at uniquely higher collision energies 
(kinetic shift) when short activation times are employed. Data interpretation of energy-resolved 
profiles has been reported to be more reliable at higher activation times due to the reduced kinetic 
shift.198 As a result, comparative analysis, and discussion of each energy-resolved dissociation 
curve were performed at an activation time, t = 1000 ms.   
Interestingly at activation time t = 1000 ms, the position and shape of the energy-resolved 
profile curves were observed uniquely differentiable for each derivatized peptide-imine allowing 
for isomeric identification of oHB=AGG, mHB=AGG, and pHB=AGG (Figure 5.3c), as well as 
for the isomeric oMB=AGG, mMB=AGG, and pMB=AGG ions (Figure 5.4c). Specifically, 
ortho species (black) may be characterized by a steady, flattened/upshifted curve and protonated 
pHB=AGG (Figure 5.3c) characterized by a steep dissociation curve for the hydroxybenzyl 
series. It is important to note though appearing in the dissociation profile plots, comparative 
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analysis of the [Bz=AGG + H]+ dissociation curve to the hydroxybenzyl and methoxybenzyl 
series should be avoided. Energy-resolved experiments of metalloporphyrin-His-containing 
peptide systems have shown a linear relationship between degrees of freedom and ion stability 
under CID conditions,205 resulting in dissociation curves with flatter slopes for larger ions.199 
This suggests a comparative analysis of ion stability for systems with different degrees of 
freedom exhibit a degree of uncertainty if the size dependence is not known and accounted.   
Comparative analysis using experimental appearance energy values in conjunction with 
DFT calculated appearance energies has been purported to better reduce the apparent “size 
effect” on energy-resolved dissociation curves.199, 200 Presumably; however, comparative 
analysis of the slope/shape of the dissociation curves from isomeric ions is indicative of the 
underlying thermochemical considerations minus the apparent size effect. Given the isomeric 
nature of the hydroxybenzyl and methoxybenzyl series precursor ions investigated and in the 
absence of DFT calculated AE values, the determined E50% values are principally used in the 
comparative analysis of the obtained dissociation curves. However, both the AE and E50% values 
are listed in Table 5.2.  
The E50% values determined for the dissociation of the hydroxybenzyl imine derivatized 
series was observed at 7.82 eV for [mHB=AGG + H]+, 8.30 eV for [pHB=AGG + H]+, and  
8.90 eV for [oHB=AGG + H]+ implicating the[oHB=AGG+H]+ ion as the most stable isomer. 
The E50% values for the methoxybenzyl series was observed at 7.91 eV for [mMB=AGG + H]
+, 
11.39 eV for [pMB=AGG + H]+, and 14.17 eV for [oMB=AGG + H]+  revealing a meta < para 
< ortho order of increasing ion stability for both peptide-imine series. Presumably, the hydrogen-
bonding interaction between the ortho-positioned -OH or -OCH3 benzyl substituent and the 
protonated N-terminal imine nitrogen (implicated by the DFT calculated low energy 
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[oHB=AGG + H]+ structure shown in Figure 4.11) acts as a stabilizing effect for the protonated 
peptide ion. However, no hydrogen-bonding interaction is available for the meta and para 
hydroxybenzyl and methoxybenzyl isomers. To better assess the observed E50% trend, the 
resonance structures of the protonated peptide imine isomers were considered. Note, the 
threshold energies determined by linear extrapolation revealed a meta < ortho < para stability 
trend. Calculated AE values are needed to assess the validity of the experimental AE values.     
  
 
  
 
Table 5.2. Experimentally determined CID profile curve E50% and appearance energies at an 
activation time of 1000 ms.  
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a)   
b)   
c)   
   
 
Figure 5.3 Collision energy resolved CID-MS2 precursor ion dissociation experiments for 
protonated Bz=AGG (yellow), pHB=AGG (red), mHB=AGG (blue), and oHB=AGG (black) at 
activation times a) t = 10 ms, b) t = 100 ms, c) t = 1000 ms, with linear extrapolation (dashed).  
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a)   
b)   
c)   
  
 
Figure 5.4 Collision energy resolved CID-MS2 precursor ion dissociation experiments for 
protonated Bz=AGG (yellow), pMB=AGG (red), mMB=AGG (blue), and oMB=AGG (black)  at 
activation times a) t = 10 ms, b) t = 100 ms, c) t = 1000 ms, with linear extrapolation (dashed).  
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Benzyl imines protonated at the imine nitrogen are particularly unique, where the 
protonated imine nitrogen can pull electron density from the benzyl moiety creating a benzyl 
carbocation that is resonance stabilized (Figure 5.5a). The benzyl imine resonance structures 
serve as benchmark stabilizing structures available to each the meta- (Figure 5.5b), ortho- 
(Figure 5.6a), and para- (Figure 5.6b) hydroxybenzyl imine species and are comparable to the 
methoxybenzyl imine resonance structures. However, an additional resonance structure 
unavailable at the meta positions was observed when the hydroxy substituent is at the para and 
ortho positions. This structure is a result of electron density pushed into the benzyl ring from the 
hydroxy oxygen, placing the ionizing charge on the oxygen further stabilizing the ortho and para 
hydroxybenzyl- ion structures of N-terminally protonated peptide-imines.   
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a)   
b)   
  
 
Figure 5.5 Resonance structures of the a) benzylimine; b) meta-hydroxybenzyl imine 
modification, where R is the peptide (i.e., AGG) starting with the N-terminal amino acid αcarbon.  
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a)   
b)   
  
 
Figure 5.6 Resonance structures of the a) ortho- b) para- hydroxybenzyl imine modification, 
where R is the peptide (i.e., AGG) starting with the N-terminal amino acid α-carbon.  
 137  
  
The slope of energy-resolved dissociation curves has been used to qualitatively determine 
the corresponding precursor ion rate of dissociation, where faster (kinetically favored) rates 
generate curves with steep slopes.199 Fast charge-mediated peptide fragmentation has been 
suggested to persist when fragmentation occurs in non-selective ways – indicative of randomized 
(entropic) protonation at various sites along the peptide backbone.198 Particularly, the 
probabilities that several activated complex configurations of protonated peptides become 
explicitly sampled (as purported by QET to determine dissociation rate)128-130 is affected by 
preferential/selective protonation at specific reaction sites, like the sidechain of basic amino acid 
residues.198 Assumedly, differences in the dissociation curve of investigated model peptide-
imine isomers can be interpreted by assessing the subtle structural differences that affect proton 
mobility and thus the energy-resolved dissociation curve slope.   
Semi-quantitative dissociation curve slope values are listed in Table 5.2, determined by 
calculating the slope of the steepest portion of the corresponding energy-resolved plot. The 
dissociation slope was observed at 0.2135 for [oHB=AGG + H]+, at 0.2706 for [mHB=AGG + 
H]+, and 0.3659 for [pHB=AGG + H]+; the steepest slope represented by the pHB species 
indicating fast dissociation. Interestingly, the observed increasing steepness order, ortho < meta 
< para, for the hydroxybenzyl imine series, was not observed of the methoxybenzyl series, where 
the [mMB=AGG + H]+ dissociation profile was observed the steepest at 0.2355. Expectedly, the 
ortho-positioned hydroxybenzyl, and methoxybenzyl modifiers resulted in the flattest 
dissociation slopes likely because the apparent hydrogen-bonding interaction at the protonated 
N-terminal imine nitrogen in conjunction with resonance stabilizing effects promote selective 
protonation at the N-terminus.   
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However, it was not readily clear the reason the dissociation curve slope for the para- 
peptide-imine analog was observed as the steepest amongst the hydroxybenzyl series, while 
shallower than the meta- analog for the methoxybenzyl series (Figure 5.4c). Possibly the hydroxy 
substituent of the HB series participates in intramolecular hydrogen-transfer reactions that 
increase the incidence of protonation (proton mobility) at active sites along the peptide 
backbone, apparently less likely with benzyl methoxy substituents. Scheme 5.2 proposes an 
intramolecular hydrogen-transfer mechanism for generating a protonated (iminomethyl) 
phenolate peptide ion species from a protonated pHB derivatized peptide.  
 The mechanism is initiated by protonation at the imine nitrogen followed by proton 
transfer from the hydroxy substituent to a reactive site along the peptide backbone, resulting in 
a phenolate ion with a net positive charge. Resonance stabilization of the intermediate 
(iminomethyl) phenolate ion species is possible at para position, making the para-hydroxy 
substituent position assumedly more acidic than the meta position. However, at the ortho 
position, the phenolate oxygen may abstract the hydrogen from the protonated N-terminal imine 
nitrogen regenerating the first structure (Scheme 5.3). In this case, it is plausible the entropic 
mobilization of the ionizing proton is greatest for protonated pHB derivatized AGG enhanced 
by the apparent acidic hydroxy substituent at the para-position and least at the ortho position due 
to that apparent N-terminal hydrogen-bonding and resonance stabilization effects promoting N-
terminal imine protonation. Likely the hydrogen-bonding and resonance stabilizing effects 
dominate for the methoxybenzyl series, resulting in the ortho < para < meta observed dissociation 
slope trend.  
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Scheme 5.2 (4-Iminomethyl) phenolate proton migration  
  
 
  
 
Scheme 5.3 (2-Iminomethyl) phenolate proton migration termination cycle  
  
The energy-resolved product ion formation profiles shown in Figure 5.7 represent the yǂ 
ion yields from CID-MS2 of benzyl- and hydroxybenzyl imine AGG over the stepwise increase 
of the collision energy at 10 ms, 100 ms, and 1000 ms activation times. Figure 5.8 shows the yǂ 
profiles for the methoxybenzyl imine series. Product ion profiles were created by plotting 
product ion yield (Equation 5.2) as a function of collision energy: where Ip is the product ion 
intensity and Itotal the total sum of ion intensities.  
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Equation 5.2                       𝑃𝑟𝑜𝑑𝑢𝑐𝑡 𝑖𝑜𝑛 𝑦𝑖𝑒𝑙𝑑 (𝑃𝑌) =  
𝐼𝑝
𝐼𝑡𝑜𝑡𝑎𝑙
       
                
The position and shape of each yǂ formation profile mirror the dissociation profile of the 
corresponding precursor ion, suggesting the energy and rate characteristics of the formation 
profiles are governed by the dissociation chemistry and structure of the precursor ion.195 
Comparative analysis of yǂ ion formation curves was therefore evaluated in terms of the ortho, 
para, and meta-structures of the hydroxybenzyl and methoxybenzyl imine AGG precursor ions. 
Specifically, yǂ ion formation was evaluated using yǂ product ion yield at 100% dissociation of 
the precursor ion known as PYmax represented by the leveling off (tail) of the profile curve.  
The PYmax determined for the formation of y
ǂ were observed at 0.3503 ± 0.0150 for 
dissociation of [Bz=AGG + H]+, 0.4200 ± 0.0255 for [mHB=AGG + H]+, 0.4279 ± 0.0244 for  
[pHB=AGG + H]+, and 0.4505 ± 0.01815 for [oHB=AGG + H]+. The order of increasing PYmax 
(meta < para < ortho) is also observed for the methoxybenzyl imine series and is consistent with 
the stability order for the corresponding protonated imine-peptide precursor ions determined 
from E50% values. Possibly, the same resonance and hydrogen-bonding effects that appear to 
influence the observed stability of the protonated N-terminal peptide-imine isomers also promote 
yǂ product ion yield when the modifier structure likely cause selective protonation at the N-
terminal imine nitrogen.   
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a)   
b)   
c)   
  
 
Figure 5.7 Collision energy resolved CID-MS2 yǂ ion formation profiles for protonated Bz=AGG 
(yellow), pHB=AGG (red), mHB=AGG (blue), and oHB=AGG (black) at activation times a) t = 
10 ms, b) t = 100 ms, c) t = 1000 ms.  
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a)   
b)   
c)   
  
 
Figure 5.8 Collision energy resolved CID-MS2 yǂ ion formation profiles for protonated Bz=AGG 
(yellow), pMB=AGG (red), mMB=AGG (blue), and oMB=AGG (black) at activation times a) t = 
10 ms, b) t = 100 ms, c) t = 1000 ms. 
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5.3 Conclusions  
The effect imine modifier structure has on the general fragmentation pattern of protonated 
imine-modified peptides was probed by comparing the CID spectra of model peptide AGG, 
derivatized by condensation reaction with benzaldehyde (Bz), and ortho (o), para (p), and meta 
(m) versions of hydroxybenzaldehyde (HB) and methoxybenzaldehyde (MB). CID of [Bz=AGG 
+ H]+ (having no substituent on the benzyl ring) showed a less extensive series of a and b ions 
compared to the HB and MB versions. A notable difference observed when comparing the CID 
mass spectra of the ortho, para, and meta isomers of protonated HB=AGG and MB=AGG were 
the intensity of the b2 and a2 ions.   
The yǂ ion peak was observed as the most intense peak (100%) for each HB and MB isomer, 
despite the disrupted hydrogen bonding interaction between the protonated imine nitrogen and 
the ortho-positioned substituent oxygen for the meta and para isomers. Presumably, eliminating 
the hydrogen-bonding interaction would reduce the competitiveness of N-terminal imine 
protonation implicated as the initiating step for an imidazole-one pathway for yǂ ion formation. 
Energy-resolved CID tandem mass spectrometry experiments were performed to further 
investigate the dissociation behavior of imine-derivatized peptides and the formation of the yǂ 
ion.   
At an activation time of t =1000 ms, the energy-resolved CID profiles of the model HB 
and MB peptide-imines qualitatively revealed the effect the modifier structure has on the peptide 
precursor ion stability in terms fragmentation yield. Notably, the observed E50% values revealed 
the energy requirement to fragment 50% of the precursor ion intensity followed a meta < para < 
ortho trend in increasing order, implicating the meta species as the least stable of the isomers. 
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Additionally, the dissociation slope values indicated the protonated ortho HB and MB peptide-
imine species dissociate at the slowest rates amongst each isomeric series.  
 Resonance structures of the protonated HB and MB peptide-imine ions revealed 
stabilization of the cation at the protonated imine nitrogen likely plays a significant role in the 
rate of dissociation and overall stability of the previously determined intrinsic structure of 
protonated peptide-imines (Chapter 4).185 Specifically, resonance, N-terminal hydrogen 
bonding, and benzyl substituent acidity appear to influence the entropic mobilization of the 
ionizing proton to various active sites along the peptide backbone qualitatively indicated by the 
shape and position of the obtained energy-resolved dissociation curves. Comparison of energy-
resolved yǂ ion formation profiles generated from CID of the protonated HB and MB peptide-
imines indicated the formation profile curve shape appears to retain the CID dissociation profile 
shape of the corresponding precursor ion. Additionally, the observed max yǂ product ion yield 
for each protonated peptide-imine suggested favorable elimination of the N-terminal amino acid 
is governed by the structural characteristics which influence selective N-terminal imine 
protonation.   
Consequently, this unambiguous observation could not have been explicitly made from 
direct interpretation of CID mass spectra alone, given each HB and MB isomer generated the yǂ 
ion at 100% relative intensity. Additionally, the unique shape and position of the energy-resolved 
dissociation curves allowed for isomeric identification within the HB and MB peptide-imine 
series, respectively, that would have been difficult from direct interpretation CID mass spectra.  
Undoubtedly, these experiments further implicated the importance of CID ion intensity data for 
evaluating the underlying dissociation chemistry of peptide ions and isomeric differentiation.   
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CHAPTER 6  
INVESTIGATION OF EVEN-ELECTRON [M-H]+ IONS 
GENERATED FROM CID OF METAL-CATIONIZED  
PEPTIDE-IMINES, [M+Ag]+   
6.1 Introduction  
As mentioned, recent studies have demonstrated that peptide identification is negatively 
influenced by the macrocyclization of b ions which open at various positions resulting in the loss 
of sequence information, known as sequence scrambling.82, 206-213 In response to evidence 
macrocyclization is initiated by nucleophilic attack of the N-terminal amine upon the b ion 
oxazolone ring,29 N-terminal derivatization strategies have been investigated to diminish or 
eliminate the effects of sequence scrambling and enhance CID-MSn approaches to direct peptide 
identification. Chapter 4 and Chapter 5 described an investigation into Schiff base, N-terminal 
amine to imine derivatization of singly protonated peptides which demonstrated elimination of 
scrambling and CID mass spectra rich in a and b type ions indicative of charge mediated 
pathways.   
As mentioned, in contrast to protonated peptides, metal-cationized peptide ions have been 
proposed to fragment along predominately charge-remote pathways.92, 95-98 Fragmentation of 
metal-cationized peptide ions have been observed to commonly generate even-electron bx-H, ax-
H, and yz-H ions indicative of hydride abstraction.
87, 92, 94 As an extension to the Schiff base 
derivation method, the fragmentation pattern of metal-cationized peptide imines by argentination 
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were investigated to provide a comparison for the dissociation behavior of the protonated and 
cationized analogs of imine-derivatized peptides.  
  
6.2. Results and Discussion  
6.2.1 CID of silver-cationized peptide-imines, [M+Ag]+   
To probe for the sequence information produced by CID of metal-cationized peptides, the 
fragmentation patterns of the Ag+-cationized oMB=GGG (Figure 6.1a), oMB=VAAF (Figure 
6.1b), and oMB=YGGFL (Figure 6.1c) ions ([M + Ag]+) were obtained. The dominate product 
ion peak created by CID of silver-cationized peptide imines was [b2-H + Ag]
+ at m/z 339 for 
oMB=GGG, [b3-H + Ag]
+ at m/z 466 for oMB=VAAF, and [b4-H + Ag]
+ at m/z 649 for 
oMB=YGGFL. Also observed were the [b2+OH + Ag]
+ and [a2-H + Ag]
+ ions at m/z 357 and 
311, respectively, for oMB=GGG; the [b3+OH + Ag]
+ and [a3-H + Ag]
+ ions at m/z 484 and 438, 
respectively, for oMB=VAAF; and the [b4+OH + Ag]
+ and [a4-H + Ag]
+ ions at m/z 667 and 
621, respectively, for oMB=YGGFL. These product ions are commonly observed during CID of 
metal-cationized peptides.95, 158, 159   
The novel elimination of the N-terminal amino acid observed for protonated peptide 
imines was not observed for silver-cationized oMB=VAAF nor silver-cationized oMB=YGGFL. 
It was unclear from CID of silver-cationized oMB=GGG whether N-terminal amino acid 
elimination was observed as the m/z 357 peak observed for silver-cationized oMB=GGG (Figure 
6.1a) is the m/z value of both the [b2 + OH + Ag]
+ and the possible yǂ ion. However, CID of other 
silver-cationized Bz=AGG did not generate the m/z 327 product ion indicative of losing the 
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residue mass of alanine (71 u). Presumably, an N-terminal amino acid elimination pathway is 
not competitive for silver-cationized peptide-imines.   
Note the conventional sequence ion nomenclature is used to define amide bond cleavage 
sites despite the modified N-terminus. Specifically, the bx-H and ax-H nomenclature is used to 
indicate a product ion of its type with one less hydrogen atom (extracted during fragmentation). 
However, note the distinction does not alter the classical mass of the neutral loss creating the 
specific sequence ions (e.g., an eliminated C-terminal glycine residue is still a loss of 75 u from 
the precursor ion mass). The bx+OH nomenclature indicates the formation of a b type ion 
terminated by a carboxy group as described by Scheme 1.11, instead of an oxazolone ring.   
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Figure 6.1 CID spectra of [M + 107Ag]+ ions where M is defined as a) oMB=GGG, b) 
oMB=VAAF, and c) oMB=YGGFL.  
a) 
b) 
c) 
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Interestingly, CID of each silver-cationized peptide imine generated a product ion peak 
consistent with eliminating the mass of 107AgH (108 u), indicated by product ion m/z 306 for  
[oMB=GGG + Ag]+, m/z 523 for [oMB=VAAF + Ag]+, and m/z 672 for [oMB=YGGFL + Ag]+. 
Evidence (not shown here) confirming the loss of 108 u as the elimination of silver hydride, was 
obtained through independent CID trails of the isolated [M+ 109Ag]+ isotopic peak where the 
analogous loss of 110 u was observed indicating the elimination 109AgH. More interestingly the 
elimination of silver hydride implicated the resulting product ion as an even-electron imine-
modified peptide cation ([M-H]+), or more plainly an imine modified peptide ion without an 
ionizing proton. It is important to note, elimination of AgH has been reported for CID of Ag(I) 
complexes with 2-aminoanilide and benzimidazole,214 and argentinated N-allyl benzamides.215 
However, the resulting cationized N-terminally modified peptide species resulting from the 
silver-hydride elimination appear to be a unique peptide ion type for gas-phase studies.  
Logically, obtaining the fragmentation pattern of novel [M-H]+ peptide ions would provide 
a way to compare the predominantly charge-mediated fragmentation of protonated N-terminally 
modified peptides to the peptide fragmentation of the same under hydrogen deficient ([M-H]+) 
conditions. However, consistent with charge-mediated explanations of protonated peptide 
fragmentation,26 the origin of the hydride abstraction that generates the [MH]+ ion was obtained 
to better aide in interpreting the CID spectra of [M-H]+ peptide ions. Additionally, the site(s) of 
hydride abstraction was determined to help construct a possible mechanism for the formation of 
the novel even-electron peptide cation.  
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6.2.2 Identifying the abstracted hydrogen involved in AgH elimination from 
silver-cationized peptide-imines  
To probe the origin of the hydride eliminated with Ag+ or whether the hydride origin is 
distributed over multiple sites leading to the creation of the [M-H]+ peptide ion, CID of silver-
cationized peptide imine analogs where the amide position and C-terminal hydrogens were 
exchanged for deuterium were examined (not shown). Upon CID of the [M + 107Ag]+ ions 
derived from D-labeled imine peptides, the loss of AgH was observed and not mass shifted AgD, 
signifying hydride elimination had not originated from the peptide backbone at an amide 
nitrogen nor the C-terminus. To investigate hydride loss from imine modifier, the CID spectrum 
of Ag+-cationized unlabeled AGG derivatized by reaction with benzaldehyde ([Bz=AGG + 
107Ag]+, Figure 6.2a)) and the CID spectrum of Ag+-cationized unlabeled AGG derivatized by 
reaction with d1-benzaldehyde – placing the deuterium atom on the benzyl carbon of the final 
metal-cationized peptide imine – were obtained ([d1-Bz=AGG + 107Ag]+, Figure 6.2b).   
Consistent with the types of product ions observed for CID of silver-cationized peptide 
imines investigated, the product ions observed for the dissociation of [Bz=AGG + Ag]+ included 
[b2-H + Ag]
+ at m/z 323, [a2-H + Ag]
+ at m/z 295, and [b2+OH + Ag]
+ at m/z 343 (Figure 6.2a). 
Expectedly, the analogous N-terminal containing product ions were upshifted by 1 u for the 
deuterium-labeled [d1-Bz=AGG + 
107Ag]+ species (Figure 6.2b), consistent with a deuterium in 
the place of hydrogen at the benzyl carbon. Likewise, the hydride elimination of 108 u (AgH) 
observed for dissociation of [Bz=AGG + Ag]+ was observed at 109 u (AgD) for [d1-Bz=AGG + 
Ag]+, strongly identifying the benzyl carbon as the site of hydride elimination.   
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Figure 6.2 CID spectra of [M + 107Ag]+ ions where M is identified as of a) Bz=AGG and b) 
d1Bz=AGG.  
  
  
  
   
   
a) 
b) 
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Note, a decrease in ion intensity was observed for silver-deuterium elimination (AgD) 
from [d1-Bz=AGG + Ag]
+ in Figure 6.2b when compared to AgH loss for unlabeled [Bz=AGG 
+ Ag]+ in Figure 6.2a consistent with a kinetic isotope effect, particularly associated with a 
decrease in the [M-H]+ production rate as a result of the H to D substitution. Furthermore, loss 
of 108 u (AgH) was not observed in the fragmentation pattern of [d1-Bz=AGG + Ag]
+, 
suggesting the hydride elimination is a selective mechanism not resultant of contributions from 
multiple sites, but explicitly abstracting the hydrogen atom from the benzyl carbon. Silver 
hydride elimination where the benzyl carbon hydrogen is the source of H-abstraction strongly 
suggests the generated [M-H]+ peptide ion is charged at the N-terminal nitrogen converting the 
imine modification into a nitrile.    
Optimized structures of underivatized Ag+-cationized GGG derived computationally by 
Hopkinson, Siu, and coworkers using B3LYP/DZVP have suggested its most stable structure as 
a “multiring” conformation consisting of the silver cation tetracoordinated at the three carbonyl 
oxygens and the N-terminal nitrogen.95 A proposed mechanism for the loss of AgH from model 
silver-cationized Bz=AGG upon CID is shown by Scheme 6.1, similar to the proposed 
fragmentation pathways of argentinated unmodified peptides proposed by Hopkinson, Siu, and 
coworkers.95 The proposed mechanism is initiated by conversion of Bz=AGG tetracoordinated 
to silver at the carbonyl oxygens and the imine nitrogen, to a conformer dicoordinated to silver 
at the imine nitrogen and the second residue carbonyl oxygen. The breakdown of the 
dicoordinated intermediate by attack of the second residue carbonyl by a lone pair on the 
carbonyl oxygen of the C-terminus, results in the retention of Ag on the second residue carbonyl 
oxygen and an intermediate structure terminated by an oxazolone ring. Hydride extraction is 
then accomplished by N-terminal nitrile formation transferring the hydride to silver, breaking 
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the AgO bond to release AgH and collapse of C-terminal oxazolone ring to generate the [M-H]+ 
even-electron ion.     
  
 
  
 
Scheme 6.1 Proposed mechanism for AgH loss from Ag+-cationized imine-modified peptides.  
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6.2.3 CID fragmentation pattern of even-electron [M-H]+ ions  
To investigate the general CID fragmentation pattern of [M-H]+ ions created by the loss 
of AgH from silver-cationized peptide imines, the [M-H]+ ions generated from silver-cationized 
oMB=GGG and oMB=AGG were obtained. The fragmentation patterns of protonated 
underivatized and oMB derivatized analogs were also obtained to probe for general differences 
in the generated sequence information each system provides. The CID spectra generated from 
the unmodified [M+H]+, modified [M+H]+, and [M-H]+ versions of GGG and AGG are shown 
in Figure 6.3 and Figure 6.4, respectively. For both GGG and AGG, the dominant product ion 
generated from CID of the [M-H]+ species was the b2-H ion at m/z 231 for [oMB=GGG – H]+ 
(Figure 6.3a) and m/z 245 for [oMB=AGG – H]+ (Figure 6.4a). Generation of the a2-H ion was 
also observed at m/z 203 and m/z 217 for CID of [oMB=GGG – H]+ and [oMB=AGG – H]+, 
respectively. Note the [M-H]+ nomenclature where M is a peptide imine is not indicative of 
structure but rather the mass equal to the peptide imine mass minus 1.  
Possible intramolecular H-transfer interactions that induce charge-mediated amide bond 
cleavages to form b, a, and y type ions under conditions with no ionizing (mobile) proton or with 
a fixed protonation site, have been previously reported by others.152, 216 Presumably, the proposed 
N-terminal “fixed” charge at the imine to nitrile transformation and the absent ionizing proton 
suggests the b and a ions from CID of [oMB=GGG – H]+ and [oMB=AGG – H]+ may be 
generated via the conventional oxazolone pathway outlined by Bythell et al. for peptides lacking 
a conventional “mobile” proton.216 Particularly, the formation of the bx-H and ax-H ions from 
CID of the [M-H]+ analogs suggested even without an ionizing proton, charge-mediated 
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pathways are competitive via intramolecular H-transfer reactions that generate the necessary 
protonated amide nitrogen configurations for amide bond cleavage.   
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Figure 6.3 CID spectra of a) the [M-H]+ species derived from AgH loss from [oMB=GGG + 
Ag]+, b) the [M+H]+ ion species derived from protonated oMB=GGG, and c) [GGG + H]+.  
a) 
b) 
c) 
 160  
  
   
   
   
  
 
Figure 6.4 CID spectra of a) the [M-H]+ species derived from AgH loss from [oMB=AGG +  
Ag]+, b) the [M+H]+ ion species derived from protonated oMB=AGG, and c) [AGG + H]+  
a) 
b) 
c) 
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A minor product ion species attributed to the loss of CO and H2O (- 46 u) was also observed 
for the CID of [oMB=GGG – H]+  and [oMB=AGG – H]+ at m/z 260 and m/z 274, respectively. 
Additionally, a minor product ion was observed from CID of [oMB=AGG – H]+ (Figure 6.4a) 
identified as the [b2+OH]
+ ion at m/z 263. Interestingly, the product ion m/z 249 indicative of 
losing the N-terminal residue mass of alanine (71 u) was observed for [oMB=AGG – H]+ at 
approximately 18% relative intensity, suggesting a yǂ formation pathway is available for 
“hydrogen-deficient” [M-H]+ ions. It is unclear whether the m/z 249 product ion observed for 
CID of [oMB=GGG – H]+  (Figure 6.3a) is indicative of generating the [b2+OH]+ and or the 
corresponding yǂ ion (N-terminal Gly loss, 57 u).  
For CID of protonated peptide imines ([M+H]+), the fragmentation pathway generating 
the yǂ ion was identified as a charge directed pathway initiated by protonation at the N-terminal 
imine nitrogen (Scheme 4.2b).197 A similar pathway is proposed by Scheme 6.2 for yǂ ion 
formation using the model [oMB=AGG – H]+ ion that can also be described as charge directed 
pathway, presuming a fixed charge at the N-terminal nitrile nitrogen. The proposed pathway 
begins with an attack of the nitrile carbon by the second residue amide nitrogen resulting in an 
imidazole-one intermediate similar to that proposed for [M+H]+ ions. Breakdown of the 
imidazole-one ring leads to the elimination of CO and formation of a benzylimino intermediate 
with an N-terminal a-type residue retained at the α carbon. Proton transfer leads to the 
elimination of the N-terminal amino acid a-type reside (HN=CHR, where R is the sidechain) and 
formation of the N-terminal nitrile yǂ ion with retained peptide sequence.    
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Scheme 6.2 Proposed mechanism for yǂ formation from even electron [M-H]+ ions.  
  
Compared to the fragmentation pattern of [M-H]+ ions derived from CID of Ag+cationized 
peptide imines, CID of the analogous [M+H]+ ions generated from protonated oMB=GGG 
(Figure 6.3b) and oMB=AGG (Figure 6.4b) produced more sequence ions than the [M-H]+ 
analogues including the b1 and a1 ions at m/z 176 and m/z 148 for [oMB=GGG + H]
+, 
respectively, and m/z 190 and 162 for [oMB=AGG + H], respectively.  The apparent absence of 
the b1 and a1 ions from the CID spectra of the hydrogen-deficient [M-H]
+ peptide ions are 
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consistent with decreased sequence ion formation observed for CID of peptides with highly basic 
residues that retain a charge and thus decrease proton mobility.71 Additionally, the relative 
intensity of the yǂ ion was observed less intense for N-terminal amino acid elimination from the 
oMB=GGG (Figure 6.3b), and oMB=AGG (Figure 6.3a) [M-H]+ ion species, indicating the 
elimination pathway is less competitive for the even-electron version   
To further probe the general fragmentation behavior of N-terminal modified [M-H]+ 
peptide ions, the CID spectra were obtained of [M-H]+ ions created by silver hydride elimination 
from silver-cationized oMB=VAAF and oMB=YGGFL. The fragmentation patterns of 
protonated underivatized and oMB derivatized VAAF and YGGFL were also obtained for 
comparison. The CID spectra generated from the unmodified [M+H]+, modified [M+H]+, and 
[M-H]+ versions of VAAF and YGGFL are shown in Figure 6.5 and Figure 6.6, respectively.  
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Figure 6.5 CID spectra of a) [M-H]+ derived from AgH loss from [oMB=VAAF + Ag]+, b) 
[M+H]+ derived from protonation of oMB=VAAF, and c) [VAAF + H]+.   
a) 
b) 
c) 
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Figure 6.6 CID spectra of a) [M-H]+ derived from AgH loss from [oMB=YGGFL + Ag]+, b) 
[M+H]+ derived from protonation of oMB=YGGFL, and c) [YGGFL + H]+.  
a) 
b) 
c) 
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For the CID spectrum of [oMB=VAAF – H]+  (Figure 6.5a), the most abundant product 
ion observed was the b2-H ion, followed by the b3-H ion observed at ~38% relative intensity. 
The a2-H, a3-H, b3+OH, and y
ǂ ion ions were also observed. The ion intensities of the b2, a2, and 
yǂ ions generated from CID of [oMB=VAAF + H]+ (Figure 6.5b) were observed much greater 
than the analogous b2-H, a2-H, and y
ǂ ions generated from CID of [oMB=VAAF – H]+.  
Presumably, the rate of production is greater for the b2 and a2 ions generated through classical 
charge-mediated pathways compared to the implicated intramolecular H-transfer pathways 
thought to generate sequences ions from the [M-H]+ precursors. Though missing from the CID 
spectrum [oMB=VAAF – H]+ and [oMB=VAAF + H]+, CID of unmodified [VAAF + H]+ 
(Figure 6.5c) generated the y2 ion as the most abundant product ion peak. Assumedly the N-
terminal imine or nitrile modifications, implicated to contain the ion charge, favor the formation 
of N-terminal containing product ions.   
CID of [oMB=YGGFL – H]+ (Figure 6.6a) generated the b2-H ion as the most abundant 
product ion peak, followed by the b4-H peak at ~ 70% relative intensity. Interestingly, of the tri, 
tetra, and pentapeptides investigated, the b2-H ion was observed as the most abundant peak for 
each [M-H]+ ion, though the mechanism behind the observation is unclear. Additionally, a very 
small peak less than 1% relative intensity was observed at m/z 509 indicative of losing the N-
terminal amino acid residue mass of Tyr (163 u) from [oMB=YGGFL – H]+  to generate the yǂ 
ion (Figure 6.6a). Though small, the relative intensity of the yǂ ion for the [M-H]+ species of 
oMB=YGGFL is consistent with the small peak observed for the yǂ ion generated from the 
[M+H]+ species. Presumably, the small intensity of the yǂ ion is indicative of a peptide length 
effect on the competitiveness of the N-terminal amino acid elimination pathway, because more 
available sites for amide bond cleavages exist for longer sequences.   
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Consistent with the fragmentation patterns of the oMB modified GGG, AGG, and VAAF 
peptides, CID of [oMB=YGGFL+H]+ (Figure 6.6b) generated more sequence information than 
CID of the [M-H]+ species. Specifically, the a1 and b1 ions were observed for the [M+H]
+ 
oMB=YGGFL species and consistently missing from the CID spectra of all the investigated [M-
H]+ species. However, the fragmentation pattern of both the [M-H]+ and [M+H]+ species of 
oMB=YGGFL was observed to lack the sequence scrambled product ions – identified with an 
asterisk in the CID spectrum of protonated unmodified YGGFL (Figure 6.6c). The elimination 
of the sequence scrambled ions further implicated N-terminal modification, either by imine or 
nitrile derivatization, as an effective method for eliminating the macrocyclization reaction that 
leads to the scrambling of unmodified peptides.    
  
6.3 Conclusion  
In this study, the fragmentation pattern of Ag+-cationized GGG, VAAF, and YGGFL 
imine derivatized by reaction with oMB was investigated. The product ions generated by CID 
of these [M+Ag]+ ions included a series of bx and ax type ions in the form bx-H, ax-H, and bx+OH, 
consistent with the literature. Interesting a novel product ion was observed consistent with losing 
107AgH to produce an apparent novel N-terminally modified even-electron peptide ion ([M-H]+). 
CID of isotopically labeled [d1-Bz=AGG + Ag]
+ unambiguously revealed the hydrogen 
abstracted with the silver cation originated from the benzyl carbon, strongly suggesting the 
structure of the resulting even-electron peptide ion lacks a conventional ionizing “mobile” proton 
but includes a charged N-terminal nitrile group.   
CID of these [M-H]+ ions generated bx-H, bx+OH, and ax-H type sequence ions. However, 
the b1-H and a1-H ions were characteristically not observed in the CID mass spectra of the [M-
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H]+ ions, while the corresponding analogs were observed in the CID mass spectra of the [M+H]+ 
peptide species. The reason remains unclear why CID of the [M+H] peptide imine species 
characteristically generated b1 and a1 ions, despite lacking the amide oxygen N-terminal to the 
b1 cleavage implicated in the bx – yz pathway (Scheme 1.1) for underivatized peptides. Evidence 
that a1 ions are generated through a b2 → a1 fragmentation pathway has been reported by others 
that suggests the a1 formation only occurs when the b2 ion oxazolone ring nitrogen bears the 
ionizing proton.217, 218, 219 Presumably, the b2-H ion generated from CID of N-terminally 
derivatized peptide [M-H]+ ion species has an oxazolone structure where the apparent N-terminal 
nitrile contains the ionizing charge, making breakdown to the a1-H ion unobservable. Similarly, 
it is unclear why the b2-H ion was generated as the most abundant product ion peak for each [M-
H]+ peptide species investigated. DFT and IRMPD spectroscopy studies to identify the structure 
of the b2-H ion and the [M-H]
+ precursor peptide ion would better reveal the underlying 
chemistry affecting the product ion distribution of even-electron peptide ions. However, the 
generation of a and b type sequence ions from CID of [M-H]+ peptide species, despite lacking a 
conventional ionizing “mobile” proton, suggests possible intramolecular H-transfer interactions 
mediate the creation of protonated amide nitrogen intermediates necessary for amide bond 
cleavage.  
Interestingly, both the [M-H]+ and [M+H]+ versions of the investigated N-terminally 
modified peptides generated the novel yǂ ion resulting from N-terminal amino acid residue 
elimination. The formation of the yǂ ion was observed as less intense for [M-H] ions when 
compared to the [M+H] species. Currently, the mechanism for yǂ ion formation from [M-H]+ 
species is not defined. However, the fixed charge at the presumed N-terminal nitrile group may 
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direct a nucleophilic attack at the benzyl carbon much likely the imidazole-one pathway for 
eliminating the N-terminal amino acid residue from [M+H]+ peptide imine species.   
More interestingly, the sequence scrambled product ions observed for CID of protonated 
underivatized YGGFL were not observed for CID of the [M-H]+ and [M+H]+ oMB derivatized 
YGGFL species. These observations further implicate N-terminal amine modification, whether 
by imine or nitrile derivatization, as a successful method for eliminating the macrocyclization 
event leading to sequence scrambling. However, the sequence ion rich (b, a, and y type ions) 
CID mass spectra observed for [M+H]+ peptide imines when compared to the CID mass spectra 
of the [M-H]+ analogues reiterate the importance of evaluating techniques for enhancing de novo 
peptide sequencing by multiple criteria, including: a) eliminating sequence scrambling and b) 
generating sequence informative product ions.   
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CHAPTER 7  
FUTURE DIRECTIONS   
7.1 Introduction  
Evaluation of novel peptide-imine fragmentation chemistry suggests that it may be useful 
for primary sequence identification, principally in peptidomics. CID-MS2 of small singly 
protonated N-terminal imine-peptides 3 to 5 residues long showed increased generation of 
information rich an/bn sequence ions when compared to the unmodified species. Additionally, 
the elimination of deleterious sequence scrambling events was also observed, restoring the power 
of multiple tandem MS experiments for de novo peptide sequencing.  
However, application of N-terminal imine derivatization for enhanced peptide sequencing 
may be best suited for use in focused data independent acquisition (DIA) approaches. Widely 
used database methods for peptide identification is largely representative of a data dependent 
acquisition approach (DDA). DDA describes detection of ionized analyte peptide ions during an 
MS1 scan, followed by individual isolation of only the most abundant ions to generate CID-MS2 
spectra for interpretation by database searching software.220 In contrast, DIA approaches 
essentially fragment all analyte peptide ions to collect CID-MS2 spectra, resulting in a wealth of 
sequence information for a greater number of identified peptides than DDA approaches.220 
DIA has been suggested as a favored approach for the characterization of peptides 
presented on cell surfaces by major histocompatibility complex (MHC) immunoproteins.220 
However, the fragmentation observed during DIA may still result in complex MS2 spectra 
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difficult to interpret through database or traditional de novo sequencing methods.220 
Additionally, accurate identification and analyses of MHC molecules is essential due to the 
limited amount of sample often collected.220 Possibly, the an/bn sequence ion specific and 
scrambling eliminating characteristics of N-terminal imine derivatization may improve the 
interpretability of MS2 spectra generated during DIA for successful sequencing of MHC bound 
peptides. Undoubtably, targeted systematic investigations of N-terminal imine-derivatized 
model peptides indicative of MHC immunopeptides and other non-tryptic peptides is an 
important next step.   
 
7.2 MHC Immunopeptides  
MHC proteins are an essential molecule of the immune system. Viral, tumor, and 
autoimmune epitopes have been identified and sequenced by ESI-MS approaches.221 The two 
major MHC immunoproteins include class I and class II, both of which adaptively function to 
present peptides on the surfaces of cells for immune system recognition of foreign substances.220-
224. The presented peptides thus can elicit T cell responses ranging from the coordination and 
regulation of effector cells, to lysis and infected cell death, making accurate identification of 
MHC peptides essential for research in immunology.221-223  
Comparatively, class II MHC molecules are constrained to macrophages and lymphocytes, 
while class I MHC molecules encompass almost every cell in an organism.224 MHC class I and 
class II – bond peptides can also be characterized as being 8 to 11 and 14 to 18 amino acid 
residues in length, respectively.221, 223 Using these length attributes, a targeted evaluation of N-
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terminal imine-derivatization for sequencing MHC class I and class II, and other  longer non-
tryptic peptides can be imagined.  
In addition to length, evaluating the effectiveness of N-terminal imine-derivatization for 
enhanced sequencing of immunopeptides should include a systematic investigation of model 
peptide-imines with charged amino acid sidechains such as lysine (K) and arginine (R). These 
residues have been observed to not only generate +2 and +3 charge states but also effect the 
fragmentation chemistry of unmodified peptide ions, mediating bond cleavage through 
noncovalent interactions near K and R sites which favorable compete for protonation.26, 225-228 
Assumedly, N-terminal imine-derivatization by reaction with o-methoxybenzaldehyde or 
salicylaldehyde may result in favored protonation at the N-terminal imine nitrogen due to the 
presumed resonance and hydrogen-bonding stability observed in the present work. Additionally, 
recent literature has shown guanidination effective in selectively transforming the amine at 
lysine sidechains to more basic guanidino groups while leaving the primary amine at the N-
terminus intact.229 Evaluating the fragmentation pattern of lysine containing peptides modified 
both by guandination and imine-derivatization may address the question of multiple lysine 
imine-derivatization sites. Continued investigation of the fragmentation chemistry of N-terminal 
imine-derivatized model MHC immunopeptides under these conditions will contribute to the 
gas-phase chemistry knowledge of these modified species but also push the techniques 
foreseeable use to a specialized and important area in peptidomics. 
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